{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "try:\n",
    "    import urllib2\n",
    "except ModuleNotFoundError:\n",
    "    import urllib as urllib2\n",
    "\n",
    "import webbrowser\n",
    "import os\n",
    "import bs4,  re\n",
    "from bs4 import BeautifulSoup\n",
    "import requests\n",
    "import nltk\n",
    "from nltk.tokenize import word_tokenize\n",
    "import matplotlib.pyplot as plt\n",
    "%matplotlib inline\n",
    "from datetime import datetime"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### The cell below opens (and converts to a dataframe) a csv file containing a URL that, when opened, will automatically download a csv file tuned to the prescribed search.  For example, the first search performed looked (1) myeloma, (2) USA, (3) Recruiting AND Non yet recruiting AND Active, but no longer recruiting, (4) Car-T.  The URL syntax can be found at ClinicalTrials.gov site.\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "df = pd.read_csv('./keyword_search.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>label</th>\n",
       "      <th>url</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>CarT</td>\n",
       "      <td>https://clinicaltrials.gov/ct2/results/downloa...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>MM</td>\n",
       "      <td>https://clinicaltrials.gov/ct2/results/downloa...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  label                                                url\n",
       "0  CarT  https://clinicaltrials.gov/ct2/results/downloa...\n",
       "1    MM  https://clinicaltrials.gov/ct2/results/downloa..."
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### The cells below open the url stored in the dataframe, and then moves the csv file from download to the desired file location\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "url = df['url'].tolist()\n",
    "target = url[1]\n",
    "\n",
    "try:\n",
    "    urllib2.urlretrieve(target, 'data/results.csv')\n",
    "except AttributeError:\n",
    "    urllib2.request.urlretrieve(target, 'data/results.csv')\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "df = pd.read_csv('data/results.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Rank</th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome Measures</th>\n",
       "      <th>Sponsor/Collaborators</th>\n",
       "      <th>...</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "      <th>URL</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>NCT02579824</td>\n",
       "      <td>Ascending Dose and Exploratory Expansion Study...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Myeloma</td>\n",
       "      <td>Drug: DS-3032b</td>\n",
       "      <td>Maximum Tolerated Dose (MTD) of DS-3032b in Pa...</td>\n",
       "      <td>M.D. Anderson Cancer Center|Daiichi Sankyo UK ...</td>\n",
       "      <td>...</td>\n",
       "      <td>2015-0101|NCI-2015-01873</td>\n",
       "      <td>August 2016</td>\n",
       "      <td>August 2021</td>\n",
       "      <td>August 2021</td>\n",
       "      <td>October 20, 2015</td>\n",
       "      <td>NaN</td>\n",
       "      <td>September 18, 2018</td>\n",
       "      <td>University of Texas MD Anderson Cancer Center,...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT02579824</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>NCT03492138</td>\n",
       "      <td>Ixazomib, ONC201, and Dexamethasone in Relapse...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Multiple Myeloma</td>\n",
       "      <td>Drug: ONC201|Drug: Ixazomib|Drug: Dexamethasone</td>\n",
       "      <td>Recommended phase II dose (RPTD)|Disease contr...</td>\n",
       "      <td>Ajai Chari|Icahn School of Medicine at Mount S...</td>\n",
       "      <td>...</td>\n",
       "      <td>GCO 17-2680</td>\n",
       "      <td>March 26, 2018</td>\n",
       "      <td>March 15, 2023</td>\n",
       "      <td>March 15, 2023</td>\n",
       "      <td>April 10, 2018</td>\n",
       "      <td>NaN</td>\n",
       "      <td>April 10, 2018</td>\n",
       "      <td>Icahn School of Medicine at Mount Sinai, New Y...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03492138</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3</td>\n",
       "      <td>NCT03601078</td>\n",
       "      <td>An Efficacy and Safety Study of bb2121 in Subj...</td>\n",
       "      <td>KarMMa-2</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Multiple Myeloma</td>\n",
       "      <td>Biological: bb2121</td>\n",
       "      <td>Overall response rate (ORR)- Cohort 1|Complete...</td>\n",
       "      <td>Celgene</td>\n",
       "      <td>...</td>\n",
       "      <td>BB2121-MM-002|U1111-1216-4209|2018-000264-28</td>\n",
       "      <td>November 13, 2018</td>\n",
       "      <td>March 12, 2025</td>\n",
       "      <td>March 12, 2025</td>\n",
       "      <td>July 26, 2018</td>\n",
       "      <td>NaN</td>\n",
       "      <td>November 8, 2018</td>\n",
       "      <td>Sarah Cannon Research Inst, Nashville, Tenness...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03601078</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>4</td>\n",
       "      <td>NCT03464916</td>\n",
       "      <td>Study to Evaluate the Safety and Efficacy of A...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Relapsed or Refractory Multiple Myeloma</td>\n",
       "      <td>Biological: CAR2 Anti-CD38 A2 CAR-T Cells</td>\n",
       "      <td>Determine the MTD|Determine the CAR2 Anti-CD38...</td>\n",
       "      <td>Sorrento Therapeutics, Inc.</td>\n",
       "      <td>...</td>\n",
       "      <td>SOR-CART-MM-001</td>\n",
       "      <td>April 5, 2018</td>\n",
       "      <td>April 2020</td>\n",
       "      <td>September 1, 2020</td>\n",
       "      <td>March 14, 2018</td>\n",
       "      <td>NaN</td>\n",
       "      <td>June 27, 2018</td>\n",
       "      <td>University of Pennsylvania, Abramson Cancer Ce...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03464916</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5</td>\n",
       "      <td>NCT03590652</td>\n",
       "      <td>Daratumumab, Ixazomib, Pomalidomide, and Dexam...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Relapsed/Refractory Multiple Myeloma</td>\n",
       "      <td>Drug: Ixazomib|Drug: Pomalidomide|Drug: Dexame...</td>\n",
       "      <td>Overall Response Rate|Incidence of Treatment-E...</td>\n",
       "      <td>Caitlin Costello, MD|Celgene|Takeda|Janssen, L...</td>\n",
       "      <td>...</td>\n",
       "      <td>180638</td>\n",
       "      <td>October 2018</td>\n",
       "      <td>October 1, 2020</td>\n",
       "      <td>October 1, 2021</td>\n",
       "      <td>July 18, 2018</td>\n",
       "      <td>NaN</td>\n",
       "      <td>October 23, 2018</td>\n",
       "      <td>UCSD Moores Cancer Center, La Jolla, Californi...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03590652</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 27 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "   Rank   NCT Number                                              Title  \\\n",
       "0     1  NCT02579824  Ascending Dose and Exploratory Expansion Study...   \n",
       "1     2  NCT03492138  Ixazomib, ONC201, and Dexamethasone in Relapse...   \n",
       "2     3  NCT03601078  An Efficacy and Safety Study of bb2121 in Subj...   \n",
       "3     4  NCT03464916  Study to Evaluate the Safety and Efficacy of A...   \n",
       "4     5  NCT03590652  Daratumumab, Ixazomib, Pomalidomide, and Dexam...   \n",
       "\n",
       "    Acronym      Status         Study Results  \\\n",
       "0       NaN  Recruiting  No Results Available   \n",
       "1       NaN  Recruiting  No Results Available   \n",
       "2  KarMMa-2  Recruiting  No Results Available   \n",
       "3       NaN  Recruiting  No Results Available   \n",
       "4       NaN  Recruiting  No Results Available   \n",
       "\n",
       "                                Conditions  \\\n",
       "0                                  Myeloma   \n",
       "1                         Multiple Myeloma   \n",
       "2                         Multiple Myeloma   \n",
       "3  Relapsed or Refractory Multiple Myeloma   \n",
       "4     Relapsed/Refractory Multiple Myeloma   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0                                     Drug: DS-3032b   \n",
       "1    Drug: ONC201|Drug: Ixazomib|Drug: Dexamethasone   \n",
       "2                                 Biological: bb2121   \n",
       "3          Biological: CAR2 Anti-CD38 A2 CAR-T Cells   \n",
       "4  Drug: Ixazomib|Drug: Pomalidomide|Drug: Dexame...   \n",
       "\n",
       "                                    Outcome Measures  \\\n",
       "0  Maximum Tolerated Dose (MTD) of DS-3032b in Pa...   \n",
       "1  Recommended phase II dose (RPTD)|Disease contr...   \n",
       "2  Overall response rate (ORR)- Cohort 1|Complete...   \n",
       "3  Determine the MTD|Determine the CAR2 Anti-CD38...   \n",
       "4  Overall Response Rate|Incidence of Treatment-E...   \n",
       "\n",
       "                               Sponsor/Collaborators  \\\n",
       "0  M.D. Anderson Cancer Center|Daiichi Sankyo UK ...   \n",
       "1  Ajai Chari|Icahn School of Medicine at Mount S...   \n",
       "2                                            Celgene   \n",
       "3                        Sorrento Therapeutics, Inc.   \n",
       "4  Caitlin Costello, MD|Celgene|Takeda|Janssen, L...   \n",
       "\n",
       "                      ...                       \\\n",
       "0                     ...                        \n",
       "1                     ...                        \n",
       "2                     ...                        \n",
       "3                     ...                        \n",
       "4                     ...                        \n",
       "\n",
       "                                      Other IDs         Start Date  \\\n",
       "0                      2015-0101|NCI-2015-01873        August 2016   \n",
       "1                                   GCO 17-2680     March 26, 2018   \n",
       "2  BB2121-MM-002|U1111-1216-4209|2018-000264-28  November 13, 2018   \n",
       "3                               SOR-CART-MM-001      April 5, 2018   \n",
       "4                                        180638       October 2018   \n",
       "\n",
       "  Primary Completion Date    Completion Date      First Posted  \\\n",
       "0             August 2021        August 2021  October 20, 2015   \n",
       "1          March 15, 2023     March 15, 2023    April 10, 2018   \n",
       "2          March 12, 2025     March 12, 2025     July 26, 2018   \n",
       "3              April 2020  September 1, 2020    March 14, 2018   \n",
       "4         October 1, 2020    October 1, 2021     July 18, 2018   \n",
       "\n",
       "  Results First Posted  Last Update Posted  \\\n",
       "0                  NaN  September 18, 2018   \n",
       "1                  NaN      April 10, 2018   \n",
       "2                  NaN    November 8, 2018   \n",
       "3                  NaN       June 27, 2018   \n",
       "4                  NaN    October 23, 2018   \n",
       "\n",
       "                                           Locations Study Documents  \\\n",
       "0  University of Texas MD Anderson Cancer Center,...             NaN   \n",
       "1  Icahn School of Medicine at Mount Sinai, New Y...             NaN   \n",
       "2  Sarah Cannon Research Inst, Nashville, Tenness...             NaN   \n",
       "3  University of Pennsylvania, Abramson Cancer Ce...             NaN   \n",
       "4  UCSD Moores Cancer Center, La Jolla, Californi...             NaN   \n",
       "\n",
       "                                           URL  \n",
       "0  https://ClinicalTrials.gov/show/NCT02579824  \n",
       "1  https://ClinicalTrials.gov/show/NCT03492138  \n",
       "2  https://ClinicalTrials.gov/show/NCT03601078  \n",
       "3  https://ClinicalTrials.gov/show/NCT03464916  \n",
       "4  https://ClinicalTrials.gov/show/NCT03590652  \n",
       "\n",
       "[5 rows x 27 columns]"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "df = df[['NCT Number','Title','Locations','Phases', 'Status', 'Interventions', 'Sponsor/Collaborators']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Status</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Sponsor/Collaborators</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT02579824</td>\n",
       "      <td>Ascending Dose and Exploratory Expansion Study...</td>\n",
       "      <td>University of Texas MD Anderson Cancer Center,...</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Drug: DS-3032b</td>\n",
       "      <td>M.D. Anderson Cancer Center|Daiichi Sankyo UK ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03492138</td>\n",
       "      <td>Ixazomib, ONC201, and Dexamethasone in Relapse...</td>\n",
       "      <td>Icahn School of Medicine at Mount Sinai, New Y...</td>\n",
       "      <td>Phase 1|Phase 2</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Drug: ONC201|Drug: Ixazomib|Drug: Dexamethasone</td>\n",
       "      <td>Ajai Chari|Icahn School of Medicine at Mount S...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT03601078</td>\n",
       "      <td>An Efficacy and Safety Study of bb2121 in Subj...</td>\n",
       "      <td>Sarah Cannon Research Inst, Nashville, Tenness...</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Biological: bb2121</td>\n",
       "      <td>Celgene</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT03464916</td>\n",
       "      <td>Study to Evaluate the Safety and Efficacy of A...</td>\n",
       "      <td>University of Pennsylvania, Abramson Cancer Ce...</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Biological: CAR2 Anti-CD38 A2 CAR-T Cells</td>\n",
       "      <td>Sorrento Therapeutics, Inc.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT03590652</td>\n",
       "      <td>Daratumumab, Ixazomib, Pomalidomide, and Dexam...</td>\n",
       "      <td>UCSD Moores Cancer Center, La Jolla, Californi...</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Drug: Ixazomib|Drug: Pomalidomide|Drug: Dexame...</td>\n",
       "      <td>Caitlin Costello, MD|Celgene|Takeda|Janssen, L...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                              Title  \\\n",
       "0  NCT02579824  Ascending Dose and Exploratory Expansion Study...   \n",
       "1  NCT03492138  Ixazomib, ONC201, and Dexamethasone in Relapse...   \n",
       "2  NCT03601078  An Efficacy and Safety Study of bb2121 in Subj...   \n",
       "3  NCT03464916  Study to Evaluate the Safety and Efficacy of A...   \n",
       "4  NCT03590652  Daratumumab, Ixazomib, Pomalidomide, and Dexam...   \n",
       "\n",
       "                                           Locations           Phases  \\\n",
       "0  University of Texas MD Anderson Cancer Center,...          Phase 1   \n",
       "1  Icahn School of Medicine at Mount Sinai, New Y...  Phase 1|Phase 2   \n",
       "2  Sarah Cannon Research Inst, Nashville, Tenness...          Phase 2   \n",
       "3  University of Pennsylvania, Abramson Cancer Ce...          Phase 1   \n",
       "4  UCSD Moores Cancer Center, La Jolla, Californi...          Phase 2   \n",
       "\n",
       "       Status                                      Interventions  \\\n",
       "0  Recruiting                                     Drug: DS-3032b   \n",
       "1  Recruiting    Drug: ONC201|Drug: Ixazomib|Drug: Dexamethasone   \n",
       "2  Recruiting                                 Biological: bb2121   \n",
       "3  Recruiting          Biological: CAR2 Anti-CD38 A2 CAR-T Cells   \n",
       "4  Recruiting  Drug: Ixazomib|Drug: Pomalidomide|Drug: Dexame...   \n",
       "\n",
       "                               Sponsor/Collaborators  \n",
       "0  M.D. Anderson Cancer Center|Daiichi Sankyo UK ...  \n",
       "1  Ajai Chari|Icahn School of Medicine at Mount S...  \n",
       "2                                            Celgene  \n",
       "3                        Sorrento Therapeutics, Inc.  \n",
       "4  Caitlin Costello, MD|Celgene|Takeda|Janssen, L...  "
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0                                         Drug: DS-3032b\n",
       "1        Drug: ONC201|Drug: Ixazomib|Drug: Dexamethasone\n",
       "2                                     Biological: bb2121\n",
       "3              Biological: CAR2 Anti-CD38 A2 CAR-T Cells\n",
       "4      Drug: Ixazomib|Drug: Pomalidomide|Drug: Dexame...\n",
       "5                      Drug: SAR650984|Drug: Carfilzomib\n",
       "6                                     Drug: Cabozantinib\n",
       "7      Drug: bb2121|Drug: Daratumumab|Drug: Pomalidom...\n",
       "8      Other: Laboratory Biomarker Analysis|Drug: Len...\n",
       "9      Drug: Bortezomib|Biological: Daratumumab|Drug:...\n",
       "10     Drug: Carfilzomib|Other: Chemosensitivity Assa...\n",
       "11                                       Drug: ABC294640\n",
       "12     Drug: Dexamethasone|Biological: Elotuzumab|Dru...\n",
       "13                                          Drug: ONC201\n",
       "14     Procedure: Autologous Hematopoietic Stem Cell ...\n",
       "15     Drug: GSK2857916|Drug: Lenalidomide|Drug: Dexa...\n",
       "16                               Drug: Lintuzumab AC 225\n",
       "17     Drug: ABI-009|Drug: Pomalidomide|Drug: Dexamet...\n",
       "18     Procedure: Biospecimen Collection|Device: High...\n",
       "19                                  Drug: CAR138 T Cells\n",
       "20                                      Drug: Elotuzumab\n",
       "21     Procedure: Autologous Hematopoietic Stem Cell ...\n",
       "22     Procedure: Guided Lesion Biopsies|Procedure: S...\n",
       "23                     Drug: Dabrafenib|Drug: Trametinib\n",
       "24     Drug: Carfilzomib|Drug: Ruxolitinib|Drug: Dexa...\n",
       "25                                    Drug: Blinatumomab\n",
       "26                                          Drug: MV-NIS\n",
       "27     Procedure: CS1-CAR T Therapy|Drug: Cyclophosph...\n",
       "28     Drug: Cyclophosphamide|Drug: Dexamethasone|Dru...\n",
       "29                     Drug: TEW-7197|Drug: Pomalidomide\n",
       "                             ...                        \n",
       "114    Biological: Nivolumab|Biological: Ipilimumab|B...\n",
       "115                                       Drug: MEDI7247\n",
       "116    Drug: NK cells +CliniMACs CD3 and CD56 systems...\n",
       "117                                       Drug: KPT-8602\n",
       "118    Procedure: Allogeneic Bone Marrow Transplantat...\n",
       "119    Drug: busulfan|Drug: cyclophosphamide|Biologic...\n",
       "120    Drug: Adavosertib|Drug: Afatinib|Drug: Binimet...\n",
       "121                                        Drug: AMG 397\n",
       "122              Drug: RO6870810|Biological: daratumumab\n",
       "123                                       Drug: EDO-S101\n",
       "124                    Drug: Nivolumab|Drug: Tocilizumab\n",
       "125                              Biological: NKR-2 cells\n",
       "126                                        Drug: AZD5991\n",
       "127                                      Drug: Dasatinib\n",
       "128                                        Drug: CLR 131\n",
       "129    Drug: Fludarabine|Radiation: Total-Body Irradi...\n",
       "130    Drug: Fludarabine phosphate|Drug: Thiotepa|Rad...\n",
       "131    Drug: Fludarabine|Drug: Busulfan|Radiation: To...\n",
       "132    Biological: HSCT with TBI Regimen|Biological: ...\n",
       "133             Device: 3'-deoxy-3'-[18F]fluorothymidine\n",
       "134                     Drug: rhIL-2|Biological: PNK-007\n",
       "135    Procedure: Allogeneic Hematopoietic Stem Cell ...\n",
       "136    Drug: Cyclophosphamide|Biological: Filgrastim|...\n",
       "137    Drug: Busulfan|Drug: Cyclophosphamide|Drug: Fl...\n",
       "138    Drug: Dasatinib|Other: laboratory biomarker an...\n",
       "139    Drug: Cyclophosphamide|Drug: Fludarabine Phosp...\n",
       "140    Drug: Cyclophosphamide|Drug: Cyclosporine|Proc...\n",
       "141                                      Drug: GSK525762\n",
       "142    Procedure: Allogeneic Hematopoietic Stem Cell ...\n",
       "143    Drug: INCB053914|Drug: I-DAC (Intermediate dos...\n",
       "Name: Interventions, Length: 144, dtype: object"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['Interventions']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['Drug: DS-3032b',\n",
       " 'Drug: ONC201|Drug: Ixazomib|Drug: Dexamethasone',\n",
       " 'Biological: bb2121',\n",
       " 'Biological: CAR2 Anti-CD38 A2 CAR-T Cells',\n",
       " 'Drug: Ixazomib|Drug: Pomalidomide|Drug: Dexamethasone|Drug: Daratumumab']"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "Meds = df['Interventions'].tolist()\n",
    "Meds[:5]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[['', 'DS-3032b'],\n",
       " ['', 'ONC201|', 'Ixazomib|', 'Dexamethasone'],\n",
       " ['Biological: bb2121'],\n",
       " ['Biological: CAR2 Anti-CD38 A2 CAR-T Cells'],\n",
       " ['', 'Ixazomib|', 'Pomalidomide|', 'Dexamethasone|', 'Daratumumab'],\n",
       " ['', 'SAR650984|', 'Carfilzomib'],\n",
       " ['', 'Cabozantinib'],\n",
       " ['',\n",
       "  'bb2121|',\n",
       "  'Daratumumab|',\n",
       "  'Pomalidomide|',\n",
       "  'Dexamethasone|',\n",
       "  'Bortezomib|',\n",
       "  'Ixazomib|',\n",
       "  'Lenalidomide'],\n",
       " ['Other: Laboratory Biomarker Analysis|',\n",
       "  'Lenalidomide|Biological: Nivolumab|Other: Pharmacological Study'],\n",
       " ['',\n",
       "  'Bortezomib|Biological: Daratumumab|',\n",
       "  'Dexamethasone|',\n",
       "  'Ixazomib|Other: Quality-of-Life Assessment'],\n",
       " ['',\n",
       "  'Carfilzomib|Other: Chemosensitivity Assay|',\n",
       "  'Dexamethasone|Other: Laboratory Biomarker Analysis|',\n",
       "  'Panobinostat'],\n",
       " ['', 'ABC294640'],\n",
       " ['', 'Dexamethasone|Biological: Elotuzumab|', 'Pomalidomide'],\n",
       " ['', 'ONC201'],\n",
       " ['Procedure: Autologous Hematopoietic Stem Cell Transplantation|',\n",
       "  'Dexamethasone|',\n",
       "  'Ixazomib Citrate|Other: Laboratory Biomarker Analysis|',\n",
       "  'Pomalidomide'],\n",
       " ['',\n",
       "  'GSK2857916|',\n",
       "  'Lenalidomide|',\n",
       "  'Dexamethasone|',\n",
       "  'Bortezomib|',\n",
       "  'RP2D of GSK2857916'],\n",
       " ['', 'Lintuzumab AC 225'],\n",
       " ['', 'ABI-009|', 'Pomalidomide|', 'Dexamethasone'],\n",
       " ['Procedure: Biospecimen Collection|Device: High Throughput Screening|Other: Laboratory Biomarker Analysis'],\n",
       " ['', 'CAR138 T Cells'],\n",
       " ['', 'Elotuzumab'],\n",
       " ['Procedure: Autologous Hematopoietic Stem Cell Transplantation|',\n",
       "  'Busulfan|',\n",
       "  'Gemcitabine Hydrochloride|Other: Laboratory Biomarker Analysis|',\n",
       "  'Melphalan|',\n",
       "  'Panobinostat|Procedure: Peripheral Blood Stem Cell Transplantation|Other: Pharmacological Study'],\n",
       " ['Procedure: Guided Lesion Biopsies|Procedure: Standard Lesion Biopsies'],\n",
       " ['', 'Dabrafenib|', 'Trametinib'],\n",
       " ['', 'Carfilzomib|', 'Ruxolitinib|', 'Dexamethasone'],\n",
       " ['', 'Blinatumomab'],\n",
       " ['', 'MV-NIS'],\n",
       " ['Procedure: CS1-CAR T Therapy|',\n",
       "  'Cyclophosphamide|',\n",
       "  'Fludarabine|Procedure: Leukapheresis'],\n",
       " ['',\n",
       "  'Cyclophosphamide|',\n",
       "  'Dexamethasone|',\n",
       "  'Ixazomib Citrate|Other: Laboratory Biomarker Analysis'],\n",
       " ['', 'TEW-7197|', 'Pomalidomide'],\n",
       " ['', 'SL-401/ Pomalidomide/ Dexamethasone'],\n",
       " ['Biological: Pembrolizumab|Radiation: Radiation Therapy'],\n",
       " ['Biological: Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143|',\n",
       "  'Cyclophosphamide|',\n",
       "  'Fludarabine|Other: Laboratory Biomarker Analysis|Procedure: Leukapheresis'],\n",
       " ['', 'I-131-CLR1404|', 'dexamethasone'],\n",
       " ['Biological: ACTR087|Biological: SEA-BCMA'],\n",
       " ['', 'ACE-011|', 'Lenalidomide|', 'Dexamethasone|', 'Pomalidomide'],\n",
       " ['', 'TAK-573'],\n",
       " ['',\n",
       "  'TTI-622 Monotherapy|',\n",
       "  'TTI-622 + Rituximab|',\n",
       "  'TTI-622 + PD-1/PD-L1 Inhibitor|',\n",
       "  'TTI-622 + Proteasome-inhibitor Regimen'],\n",
       " ['Radiation: 18F-FHBG|Biological: Aldesleukin|Biological: Cellular Therapy|Procedure: Computed Tomography|Biological: Filgrastim|Other: Laboratory Biomarker Analysis|',\n",
       "  'Lenalidomide|Procedure: Leukapheresis|',\n",
       "  'Melphalan|',\n",
       "  'Plerixafor|Procedure: Positron Emission Tomography'],\n",
       " ['', 'AMG 424'],\n",
       " ['',\n",
       "  'Carfilzomib|',\n",
       "  'Dexamethasone|Biological: Nivolumab|Biological: Wild-type Reovirus'],\n",
       " ['', 'selinexor|', 'carfilzomib|', 'dexamethasone'],\n",
       " ['Biological: Abatacept|',\n",
       "  'Dexamethasone|',\n",
       "  'Ixazomib Citrate|Other: Laboratory Biomarker Analysis'],\n",
       " ['Biological: BCMA-specific CAR-expressing T Lymphocytes|',\n",
       "  'Cyclophosphamide|',\n",
       "  'Fludarabine|',\n",
       "  'Gamma-Secretase Inhibitor LY3039478|Other: Laboratory Biomarker Analysis|Other: Pharmacokinetic Study'],\n",
       " ['', 'SEA-BCMA'],\n",
       " ['Combination Product: BCMA CART + huCART19|Combination Product: CART BCMA or CART BCMA + huCART19|Combination Product: Single-dose infusion of CART BCMA or CART BCMA + huCART19'],\n",
       " ['', 'Pomalidomide|', 'Carfilzomib|', 'dexamethasone|', 'Daratumumab'],\n",
       " ['',\n",
       "  'Phase 1a: CWP232291|',\n",
       "  'Phase 1b: CWP232291, Lenalidomide, Dexamethasone'],\n",
       " ['Radiation: Total Body Irradiation|Procedure: Haploidentical Stem Cell Transplantation|Biological: CD56-Enriched Donor Lymphocyte Infusion|',\n",
       "  'Bendamustine|',\n",
       "  'Fludarabine|',\n",
       "  'Rituximab'],\n",
       " ['Biological: Dose Escalation, MEDI2228, ADC (antibody drug conjugate)|Biological: Dose Expansion, MEDI2228, ADC (antibody drug conjugate)'],\n",
       " ['Genetic: NY-ESO-1ᶜ²⁵⁹T cells|',\n",
       "  'NY-ESO-1ᶜ²⁵⁹T in combination with pembrolizumab'],\n",
       " ['',\n",
       "  'Immediate Release (IR) Formulation|',\n",
       "  'Gastro-Retentive (GR) Formulation|',\n",
       "  'Dexamethasone|',\n",
       "  'Pomalidomide'],\n",
       " ['',\n",
       "  'Clarithromycin|',\n",
       "  'Dexamethasone|',\n",
       "  'Ixazomib Citrate|',\n",
       "  'Pomalidomide'],\n",
       " ['', 'PT-112'],\n",
       " ['', 'Carfilzomib|', 'Venetoclax|', 'Dexamethasone'],\n",
       " ['', 'Melflufen|', 'Dexamethasone'],\n",
       " ['Combination Product: Dexamethasone|Combination Product: Carfilzomib'],\n",
       " ['', 'Ixazomib|', 'Pomalidomide|', 'Dexamethasone'],\n",
       " ['', 'Elotuzumab|', 'Pomalidomide|', 'Carfilzomib|', 'Dexamethasone'],\n",
       " ['',\n",
       "  'POM|',\n",
       "  'Steroids|',\n",
       "  'PLD|',\n",
       "  'CFZ|',\n",
       "  'BTZ|',\n",
       "  'CLA|',\n",
       "  'Other drugs|',\n",
       "  'CY'],\n",
       " ['', 'Dexamethasone|', 'ABT-199'],\n",
       " ['', 'Pomalidomide|', 'Dexamethasone|', 'Venetoclax'],\n",
       " ['',\n",
       "  'Carfilzomib|',\n",
       "  'Dexamethasone|',\n",
       "  'Prednisone|',\n",
       "  'Methylprednisolone|',\n",
       "  'Lenalidomide|',\n",
       "  'Pomalidomide'],\n",
       " ['', 'Elotuzumab|', 'Pomalidomide|', 'Bortezomib|', 'Dexamethasone'],\n",
       " ['', 'Dexamethasone|', 'Daratumumab|', 'Venetoclax|', 'Bortezomib'],\n",
       " ['', 'CC-93269'],\n",
       " ['Genetic: Autologous genetically modified anti-BCMA CAR transduced T cells (KITE-585)|',\n",
       "  'Cyclophosphamide|',\n",
       "  'Fludarabine'],\n",
       " ['', 'PF-06863135'],\n",
       " ['', 'CC-92480|', 'Dexamethasone'],\n",
       " ['', 'Venetoclax|', 'Pomalidomide|', 'Dexamethasone'],\n",
       " ['', 'AMG 176'],\n",
       " ['Biological: JCARH125'],\n",
       " ['Biological: BION-1301'],\n",
       " ['', 'Ixazomib|', 'Daratumumab|', 'Dexamethasone'],\n",
       " ['', 'BFCR4350A'],\n",
       " ['', 'TAK-079'],\n",
       " ['Biological: Nicotinamide Expanded Haploidentical or Mismatched Related Donor Natural Killer Cells'],\n",
       " ['', 'Carfilzomib|', 'Pomalidomide|', 'Dexamethasone'],\n",
       " ['', 'Melflufen|', 'Pomalidomide|', 'Dexamethasone'],\n",
       " ['',\n",
       "  'Ruxolitinib Oral Tablet [Jakafi]|',\n",
       "  'Lenalidomide 5Mg Oral Capsule|',\n",
       "  'Methyl Prednisolonate'],\n",
       " ['', 'Isatuximab SAR650984|', 'Cemiplimab REGN2810'],\n",
       " ['',\n",
       "  'Elotuzumab|',\n",
       "  'Pomalidomide|',\n",
       "  'Dexamethasone|Procedure: Autologous stem cell transplant|',\n",
       "  'Melphalan'],\n",
       " ['Biological: Pembrolizumab|Biological: Daratumumab'],\n",
       " ['', 'Selinexor|', 'Ixazomib|', 'Dexamethasone'],\n",
       " ['',\n",
       "  'panobinostat capsules|',\n",
       "  'bortezomib injection|',\n",
       "  'dexamethasone tablets'],\n",
       " ['', 'CC-220|', 'Dexamethasone|', 'Daratumumab|', 'Bortezomib (BTZ)'],\n",
       " ['',\n",
       "  'Selinexor|',\n",
       "  'Dexamethasone|',\n",
       "  'Lenalidomide|',\n",
       "  'Pomalidomide|',\n",
       "  'Bortezomib|',\n",
       "  'Daratumumab|',\n",
       "  'Carfilzomib'],\n",
       " ['Other: Ascorbate|', 'Melphalan'],\n",
       " ['Biological: JNJ-68284528'],\n",
       " ['', 'Dara SC|', 'Dara IV'],\n",
       " ['',\n",
       "  'Carfilzomib|',\n",
       "  'Lenalidomide|',\n",
       "  'Dexamethasone|',\n",
       "  'Daratumumab|Procedure: autologous hematopoietic cell transplantation'],\n",
       " ['Biological: P-BCMA-101 CAR-T cells|', 'Rimiducid'],\n",
       " ['',\n",
       "  'Daratumumab Subcutaneous (SC) Administration|',\n",
       "  'Recombinant Human Hyaluronidase [rHuPH20]) SC Administration'],\n",
       " ['', 'MIK665'],\n",
       " ['', 'AMG 701'],\n",
       " ['', 'isatuximab SAR650984|', 'carfilzomib|', 'dexamethasone'],\n",
       " ['',\n",
       "  'GSK2857916 frozen|',\n",
       "  'GSK2857916 lyophilized|Other: NEI-VFQ-25 Questionnaire|Other: OSDI Questionnaire|Other: EORTC QLQ-C30 Questionnaire|Other: EORTC QLQ-MY20 Questionnaire'],\n",
       " ['Biological: bb21217'],\n",
       " ['Other: Laboratory Biomarker Analysis|',\n",
       "  'Melphalan Hydrochloride|Other: Pharmacological Study'],\n",
       " ['Biological: Kappa CD28 T cells'],\n",
       " ['', 'Dexamethasone|', 'Ixazomib|', 'Lenalidomide'],\n",
       " ['', 'Pralatrexate|', 'Romidepsin'],\n",
       " ['',\n",
       "  'Abemaciclib, dexamethasone, ixazomib, pomalidomide|',\n",
       "  'Enasidenib, dexamethasone, ixazomib, pomalidomide|',\n",
       "  'Cobimetinib, dexamethasone, ixazomib, pomalidomide|',\n",
       "  'Erdafitinib, dexamethasone, ixazomib, pomalidomide|',\n",
       "  'Venetoclax, dexamethasone, ixazomib, pomalidomide|',\n",
       "  'Daratumumab, dexamethasone, ixazomib, pomalidomide'],\n",
       " ['',\n",
       "  'Ixazomib Citrate|Other: Laboratory Biomarker Analysis|',\n",
       "  'Lenalidomide'],\n",
       " ['', 'Isatuximab'],\n",
       " ['', 'JNJ-64007957'],\n",
       " ['', 'JNJ-64407564'],\n",
       " ['', 'PDR001|', 'CJM112|', 'LCL161'],\n",
       " ['', 'Selinexor|', 'Bortezomib|', 'Dexamethasone'],\n",
       " ['', 'Melflufen|', 'Dexamethasone|', 'Bortezomib|', 'Daratumumab'],\n",
       " ['', 'SGN-CD48A'],\n",
       " ['', 'Isatuximab SAR650984|', 'Pomalidomide|', 'Dexamethasone'],\n",
       " ['', 'Treatment with TINOSTAMUSTINE'],\n",
       " ['',\n",
       "  'Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody|',\n",
       "  'Daratumumab|',\n",
       "  'Lenalidomide|',\n",
       "  'Pomalidomide|',\n",
       "  'Dexamethasone'],\n",
       " ['Biological: Nivolumab|Biological: Ipilimumab|Biological: Lirilumab|Biological: Daratumumab|',\n",
       "  'Pomalidomide|',\n",
       "  'Dexamethasone'],\n",
       " ['', 'MEDI7247'],\n",
       " ['', 'NK cells +CliniMACs CD3 and CD56 systems|Biological: NK cells'],\n",
       " ['', 'KPT-8602'],\n",
       " ['Procedure: Allogeneic Bone Marrow Transplantation|Procedure: Allogeneic Hematopoietic Stem Cell Transplantation|Procedure: Autologous Hematopoietic Stem Cell Transplantation|Procedure: Autologous-Allogeneic Tandem Hematopoietic Stem Cell Transplantation|',\n",
       "  'Carmustine|',\n",
       "  'Cyclophosphamide|',\n",
       "  'Cytarabine|',\n",
       "  'Etoposide|',\n",
       "  'Fludarabine Phosphate|Other: Laboratory Biomarker Analysis|',\n",
       "  'Melphalan|',\n",
       "  'Mycophenolate Mofetil|Procedure: Peripheral Blood Stem Cell Transplantation|',\n",
       "  'Tacrolimus|Radiation: Total-Body Irradiation'],\n",
       " ['',\n",
       "  'busulfan|',\n",
       "  'cyclophosphamide|Biological: Stem cell infusion|Radiation: Total body irradiation'],\n",
       " ['',\n",
       "  'Adavosertib|',\n",
       "  'Afatinib|',\n",
       "  'Binimetinib|',\n",
       "  'Capivasertib|',\n",
       "  'Crizotinib|Other: Cytology Specimen Collection Procedure|',\n",
       "  'Dabrafenib|',\n",
       "  'Dasatinib|',\n",
       "  'Defactinib|',\n",
       "  'FGFR Inhibitor AZD4547|Other: Laboratory Biomarker Analysis|',\n",
       "  'Larotrectinib|Biological: Nivolumab|',\n",
       "  'Osimertinib|',\n",
       "  'Palbociclib|Biological: Pertuzumab|',\n",
       "  'PI3K-beta Inhibitor GSK2636771|',\n",
       "  'Sapanisertib|',\n",
       "  'Sunitinib Malate|',\n",
       "  'Taselisib|',\n",
       "  'Trametinib|Biological: Trastuzumab|Biological: Trastuzumab Emtansine|',\n",
       "  'Vismodegib'],\n",
       " ['', 'AMG 397'],\n",
       " ['', 'RO6870810|Biological: daratumumab'],\n",
       " ['', 'EDO-S101'],\n",
       " ['', 'Nivolumab|', 'Tocilizumab'],\n",
       " ['Biological: NKR-2 cells'],\n",
       " ['', 'AZD5991'],\n",
       " ['', 'Dasatinib'],\n",
       " ['', 'CLR 131'],\n",
       " ['',\n",
       "  'Fludarabine|Radiation: Total-Body Irradiation|Biological: T Cell-Depleted Donor Lymphocyte Infusion|',\n",
       "  'Cyclophosphamide|Procedure: Peripheral Blood Stem Cell Transplantation|Procedure: Allogeneic Hematopoietic Stem Cell Transplantation|',\n",
       "  'Tacrolimus|',\n",
       "  'Mycophenolate mofetil'],\n",
       " ['',\n",
       "  'Fludarabine phosphate|',\n",
       "  'Thiotepa|Radiation: Total body irradiation|Biological: Therapeutic allogeneic lymphocytes|',\n",
       "  'Cyclophosphamide|Procedure: Allogeneic hematopoietic stem cell transplantation (HSCT)|Procedure: Peripheral blood stem cell transplantation|',\n",
       "  'Tacrolimus|',\n",
       "  'Mycophenolate mofetil'],\n",
       " ['',\n",
       "  'Fludarabine|',\n",
       "  'Busulfan|Radiation: Total Body Irradiation (TBI)|Biological: Donor Lymphocyte Infusion (DLI)|',\n",
       "  'Cyclophosphamide (CY)|',\n",
       "  'Tacrolimus|',\n",
       "  'Mycophenolate mofetil|Device: Allogeneic hematopoietic stem cell transplantation|Procedure: Peripheral blood stem cell transplantation (PBSCT)'],\n",
       " ['Biological: HSCT with TBI Regimen|Biological: HSCT with Non-TBI Regimen'],\n",
       " [\"Device: 3'-deoxy-3'-[18F]fluorothymidine\"],\n",
       " ['', 'rhIL-2|Biological: PNK-007'],\n",
       " ['Procedure: Allogeneic Hematopoietic Stem Cell Transplantation|Biological: Irradiated Allogeneic Cells'],\n",
       " ['',\n",
       "  'Cyclophosphamide|Biological: Filgrastim|',\n",
       "  'Fludarabine Phosphate|Procedure: Laboratory Biomarker Analysis|',\n",
       "  'Mycophenolate Mofetil|Procedure: Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation|Procedure: Peripheral Blood Stem Cell Transplantation|',\n",
       "  'Tacrolimus|Radiation: Total-Body Irradiation'],\n",
       " ['',\n",
       "  'Busulfan|',\n",
       "  'Cyclophosphamide|',\n",
       "  'Fludarabine Phosphate|Procedure: Hematopoietic Cell Transplantation|Other: Laboratory Biomarker Analysis|',\n",
       "  'Melphalan Hydrochloride|',\n",
       "  'Mycophenolate Mofetil|Procedure: Peripheral Blood Stem Cell Transplantation|Other: Quality-of-Life Assessment|',\n",
       "  'Tacrolimus|Radiation: Total-Body Irradiation'],\n",
       " ['', 'Dasatinib|Other: laboratory biomarker analysis'],\n",
       " ['',\n",
       "  'Cyclophosphamide|',\n",
       "  'Fludarabine Phosphate|Other: Laboratory Biomarker Analysis|Procedure: Peripheral Blood Stem Cell Transplantation|Radiation: Total-Body Irradiation'],\n",
       " ['',\n",
       "  'Cyclophosphamide|',\n",
       "  'Cyclosporine|Procedure: Double-Unit Umbilical Cord Blood Transplantation|',\n",
       "  'Fludarabine Phosphate|Other: Laboratory Biomarker Analysis|',\n",
       "  'Mycophenolate Mofetil|Radiation: Total-Body Irradiation|Procedure: Umbilical Cord Blood Transplantation|',\n",
       "  'Thiotepa'],\n",
       " ['', 'GSK525762'],\n",
       " ['Procedure: Allogeneic Hematopoietic Stem Cell Transplantation|',\n",
       "  'Cyclosporine|',\n",
       "  'Fludarabine Phosphate|Other: Laboratory Biomarker Analysis|',\n",
       "  'Mycophenolate Mofetil|Procedure: Peripheral Blood Stem Cell Transplantation|',\n",
       "  'Sirolimus|Radiation: Total-Body Irradiation'],\n",
       " ['',\n",
       "  'INCB053914|',\n",
       "  'I-DAC (Intermediate dose cytarabine)|',\n",
       "  'Azacitidine|',\n",
       "  'Ruxolitinib']]"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "a = 'Drug: '\n",
    "b = '|'\n",
    "lst=[]\n",
    "for i in range(len(Meds)):\n",
    "    lst.append(Meds[i].split(a))\n",
    "    \n",
    "lst"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[[''],\n",
       " ['DS-3032b'],\n",
       " [''],\n",
       " ['ONC201', ''],\n",
       " ['Ixazomib', ''],\n",
       " ['Dexamethasone'],\n",
       " ['Biological: bb2121'],\n",
       " ['Biological: CAR2 Anti-CD38 A2 CAR-T Cells'],\n",
       " [''],\n",
       " ['Ixazomib', ''],\n",
       " ['Pomalidomide', ''],\n",
       " ['Dexamethasone', ''],\n",
       " ['Daratumumab'],\n",
       " [''],\n",
       " ['SAR650984', ''],\n",
       " ['Carfilzomib'],\n",
       " [''],\n",
       " ['Cabozantinib'],\n",
       " [''],\n",
       " ['bb2121', ''],\n",
       " ['Daratumumab', ''],\n",
       " ['Pomalidomide', ''],\n",
       " ['Dexamethasone', ''],\n",
       " ['Bortezomib', ''],\n",
       " ['Ixazomib', ''],\n",
       " ['Lenalidomide'],\n",
       " ['Other: Laboratory Biomarker Analysis', ''],\n",
       " ['Lenalidomide', 'Biological: Nivolumab', 'Other: Pharmacological Study'],\n",
       " [''],\n",
       " ['Bortezomib', 'Biological: Daratumumab', ''],\n",
       " ['Dexamethasone', ''],\n",
       " ['Ixazomib', 'Other: Quality-of-Life Assessment'],\n",
       " [''],\n",
       " ['Carfilzomib', 'Other: Chemosensitivity Assay', ''],\n",
       " ['Dexamethasone', 'Other: Laboratory Biomarker Analysis', ''],\n",
       " ['Panobinostat'],\n",
       " [''],\n",
       " ['ABC294640'],\n",
       " [''],\n",
       " ['Dexamethasone', 'Biological: Elotuzumab', ''],\n",
       " ['Pomalidomide'],\n",
       " [''],\n",
       " ['ONC201'],\n",
       " ['Procedure: Autologous Hematopoietic Stem Cell Transplantation', ''],\n",
       " ['Dexamethasone', ''],\n",
       " ['Ixazomib Citrate', 'Other: Laboratory Biomarker Analysis', ''],\n",
       " ['Pomalidomide'],\n",
       " [''],\n",
       " ['GSK2857916', ''],\n",
       " ['Lenalidomide', ''],\n",
       " ['Dexamethasone', ''],\n",
       " ['Bortezomib', ''],\n",
       " ['RP2D of GSK2857916'],\n",
       " [''],\n",
       " ['Lintuzumab AC 225'],\n",
       " [''],\n",
       " ['ABI-009', ''],\n",
       " ['Pomalidomide', ''],\n",
       " ['Dexamethasone'],\n",
       " ['Procedure: Biospecimen Collection',\n",
       "  'Device: High Throughput Screening',\n",
       "  'Other: Laboratory Biomarker Analysis'],\n",
       " [''],\n",
       " ['CAR138 T Cells'],\n",
       " [''],\n",
       " ['Elotuzumab'],\n",
       " ['Procedure: Autologous Hematopoietic Stem Cell Transplantation', ''],\n",
       " ['Busulfan', ''],\n",
       " ['Gemcitabine Hydrochloride', 'Other: Laboratory Biomarker Analysis', ''],\n",
       " ['Melphalan', ''],\n",
       " ['Panobinostat',\n",
       "  'Procedure: Peripheral Blood Stem Cell Transplantation',\n",
       "  'Other: Pharmacological Study'],\n",
       " ['Procedure: Guided Lesion Biopsies', 'Procedure: Standard Lesion Biopsies'],\n",
       " [''],\n",
       " ['Dabrafenib', ''],\n",
       " ['Trametinib'],\n",
       " [''],\n",
       " ['Carfilzomib', ''],\n",
       " ['Ruxolitinib', ''],\n",
       " ['Dexamethasone'],\n",
       " [''],\n",
       " ['Blinatumomab'],\n",
       " [''],\n",
       " ['MV-NIS'],\n",
       " ['Procedure: CS1-CAR T Therapy', ''],\n",
       " ['Cyclophosphamide', ''],\n",
       " ['Fludarabine', 'Procedure: Leukapheresis'],\n",
       " [''],\n",
       " ['Cyclophosphamide', ''],\n",
       " ['Dexamethasone', ''],\n",
       " ['Ixazomib Citrate', 'Other: Laboratory Biomarker Analysis'],\n",
       " [''],\n",
       " ['TEW-7197', ''],\n",
       " ['Pomalidomide'],\n",
       " [''],\n",
       " ['SL-401/ Pomalidomide/ Dexamethasone'],\n",
       " ['Biological: Pembrolizumab', 'Radiation: Radiation Therapy'],\n",
       " ['Biological: Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143',\n",
       "  ''],\n",
       " ['Cyclophosphamide', ''],\n",
       " ['Fludarabine',\n",
       "  'Other: Laboratory Biomarker Analysis',\n",
       "  'Procedure: Leukapheresis'],\n",
       " [''],\n",
       " ['I-131-CLR1404', ''],\n",
       " ['dexamethasone'],\n",
       " ['Biological: ACTR087', 'Biological: SEA-BCMA'],\n",
       " [''],\n",
       " ['ACE-011', ''],\n",
       " ['Lenalidomide', ''],\n",
       " ['Dexamethasone', ''],\n",
       " ['Pomalidomide'],\n",
       " [''],\n",
       " ['TAK-573'],\n",
       " [''],\n",
       " ['TTI-622 Monotherapy', ''],\n",
       " ['TTI-622 + Rituximab', ''],\n",
       " ['TTI-622 + PD-1/PD-L1 Inhibitor', ''],\n",
       " ['TTI-622 + Proteasome-inhibitor Regimen'],\n",
       " ['Radiation: 18F-FHBG',\n",
       "  'Biological: Aldesleukin',\n",
       "  'Biological: Cellular Therapy',\n",
       "  'Procedure: Computed Tomography',\n",
       "  'Biological: Filgrastim',\n",
       "  'Other: Laboratory Biomarker Analysis',\n",
       "  ''],\n",
       " ['Lenalidomide', 'Procedure: Leukapheresis', ''],\n",
       " ['Melphalan', ''],\n",
       " ['Plerixafor', 'Procedure: Positron Emission Tomography'],\n",
       " [''],\n",
       " ['AMG 424'],\n",
       " [''],\n",
       " ['Carfilzomib', ''],\n",
       " ['Dexamethasone', 'Biological: Nivolumab', 'Biological: Wild-type Reovirus'],\n",
       " [''],\n",
       " ['selinexor', ''],\n",
       " ['carfilzomib', ''],\n",
       " ['dexamethasone'],\n",
       " ['Biological: Abatacept', ''],\n",
       " ['Dexamethasone', ''],\n",
       " ['Ixazomib Citrate', 'Other: Laboratory Biomarker Analysis'],\n",
       " ['Biological: BCMA-specific CAR-expressing T Lymphocytes', ''],\n",
       " ['Cyclophosphamide', ''],\n",
       " ['Fludarabine', ''],\n",
       " ['Gamma-Secretase Inhibitor LY3039478',\n",
       "  'Other: Laboratory Biomarker Analysis',\n",
       "  'Other: Pharmacokinetic Study'],\n",
       " [''],\n",
       " ['SEA-BCMA'],\n",
       " ['Combination Product: BCMA CART + huCART19',\n",
       "  'Combination Product: CART BCMA or CART BCMA + huCART19',\n",
       "  'Combination Product: Single-dose infusion of CART BCMA or CART BCMA + huCART19'],\n",
       " [''],\n",
       " ['Pomalidomide', ''],\n",
       " ['Carfilzomib', ''],\n",
       " ['dexamethasone', ''],\n",
       " ['Daratumumab'],\n",
       " [''],\n",
       " ['Phase 1a: CWP232291', ''],\n",
       " ['Phase 1b: CWP232291, Lenalidomide, Dexamethasone'],\n",
       " ['Radiation: Total Body Irradiation',\n",
       "  'Procedure: Haploidentical Stem Cell Transplantation',\n",
       "  'Biological: CD56-Enriched Donor Lymphocyte Infusion',\n",
       "  ''],\n",
       " ['Bendamustine', ''],\n",
       " ['Fludarabine', ''],\n",
       " ['Rituximab'],\n",
       " ['Biological: Dose Escalation, MEDI2228, ADC (antibody drug conjugate)',\n",
       "  'Biological: Dose Expansion, MEDI2228, ADC (antibody drug conjugate)'],\n",
       " ['Genetic: NY-ESO-1ᶜ²⁵⁹T cells', ''],\n",
       " ['NY-ESO-1ᶜ²⁵⁹T in combination with pembrolizumab'],\n",
       " [''],\n",
       " ['Immediate Release (IR) Formulation', ''],\n",
       " ['Gastro-Retentive (GR) Formulation', ''],\n",
       " ['Dexamethasone', ''],\n",
       " ['Pomalidomide'],\n",
       " [''],\n",
       " ['Clarithromycin', ''],\n",
       " ['Dexamethasone', ''],\n",
       " ['Ixazomib Citrate', ''],\n",
       " ['Pomalidomide'],\n",
       " [''],\n",
       " ['PT-112'],\n",
       " [''],\n",
       " ['Carfilzomib', ''],\n",
       " ['Venetoclax', ''],\n",
       " ['Dexamethasone'],\n",
       " [''],\n",
       " ['Melflufen', ''],\n",
       " ['Dexamethasone'],\n",
       " ['Combination Product: Dexamethasone', 'Combination Product: Carfilzomib'],\n",
       " [''],\n",
       " ['Ixazomib', ''],\n",
       " ['Pomalidomide', ''],\n",
       " ['Dexamethasone'],\n",
       " [''],\n",
       " ['Elotuzumab', ''],\n",
       " ['Pomalidomide', ''],\n",
       " ['Carfilzomib', ''],\n",
       " ['Dexamethasone'],\n",
       " [''],\n",
       " ['POM', ''],\n",
       " ['Steroids', ''],\n",
       " ['PLD', ''],\n",
       " ['CFZ', ''],\n",
       " ['BTZ', ''],\n",
       " ['CLA', ''],\n",
       " ['Other drugs', ''],\n",
       " ['CY'],\n",
       " [''],\n",
       " ['Dexamethasone', ''],\n",
       " ['ABT-199'],\n",
       " [''],\n",
       " ['Pomalidomide', ''],\n",
       " ['Dexamethasone', ''],\n",
       " ['Venetoclax'],\n",
       " [''],\n",
       " ['Carfilzomib', ''],\n",
       " ['Dexamethasone', ''],\n",
       " ['Prednisone', ''],\n",
       " ['Methylprednisolone', ''],\n",
       " ['Lenalidomide', ''],\n",
       " ['Pomalidomide'],\n",
       " [''],\n",
       " ['Elotuzumab', ''],\n",
       " ['Pomalidomide', ''],\n",
       " ['Bortezomib', ''],\n",
       " ['Dexamethasone'],\n",
       " [''],\n",
       " ['Dexamethasone', ''],\n",
       " ['Daratumumab', ''],\n",
       " ['Venetoclax', ''],\n",
       " ['Bortezomib'],\n",
       " [''],\n",
       " ['CC-93269'],\n",
       " ['Genetic: Autologous genetically modified anti-BCMA CAR transduced T cells (KITE-585)',\n",
       "  ''],\n",
       " ['Cyclophosphamide', ''],\n",
       " ['Fludarabine'],\n",
       " [''],\n",
       " ['PF-06863135'],\n",
       " [''],\n",
       " ['CC-92480', ''],\n",
       " ['Dexamethasone'],\n",
       " [''],\n",
       " ['Venetoclax', ''],\n",
       " ['Pomalidomide', ''],\n",
       " ['Dexamethasone'],\n",
       " [''],\n",
       " ['AMG 176'],\n",
       " ['Biological: JCARH125'],\n",
       " ['Biological: BION-1301'],\n",
       " [''],\n",
       " ['Ixazomib', ''],\n",
       " ['Daratumumab', ''],\n",
       " ['Dexamethasone'],\n",
       " [''],\n",
       " ['BFCR4350A'],\n",
       " [''],\n",
       " ['TAK-079'],\n",
       " ['Biological: Nicotinamide Expanded Haploidentical or Mismatched Related Donor Natural Killer Cells'],\n",
       " [''],\n",
       " ['Carfilzomib', ''],\n",
       " ['Pomalidomide', ''],\n",
       " ['Dexamethasone'],\n",
       " [''],\n",
       " ['Melflufen', ''],\n",
       " ['Pomalidomide', ''],\n",
       " ['Dexamethasone'],\n",
       " [''],\n",
       " ['Ruxolitinib Oral Tablet [Jakafi]', ''],\n",
       " ['Lenalidomide 5Mg Oral Capsule', ''],\n",
       " ['Methyl Prednisolonate'],\n",
       " [''],\n",
       " ['Isatuximab SAR650984', ''],\n",
       " ['Cemiplimab REGN2810'],\n",
       " [''],\n",
       " ['Elotuzumab', ''],\n",
       " ['Pomalidomide', ''],\n",
       " ['Dexamethasone', 'Procedure: Autologous stem cell transplant', ''],\n",
       " ['Melphalan'],\n",
       " ['Biological: Pembrolizumab', 'Biological: Daratumumab'],\n",
       " [''],\n",
       " ['Selinexor', ''],\n",
       " ['Ixazomib', ''],\n",
       " ['Dexamethasone'],\n",
       " [''],\n",
       " ['panobinostat capsules', ''],\n",
       " ['bortezomib injection', ''],\n",
       " ['dexamethasone tablets'],\n",
       " [''],\n",
       " ['CC-220', ''],\n",
       " ['Dexamethasone', ''],\n",
       " ['Daratumumab', ''],\n",
       " ['Bortezomib (BTZ)'],\n",
       " [''],\n",
       " ['Selinexor', ''],\n",
       " ['Dexamethasone', ''],\n",
       " ['Lenalidomide', ''],\n",
       " ['Pomalidomide', ''],\n",
       " ['Bortezomib', ''],\n",
       " ['Daratumumab', ''],\n",
       " ['Carfilzomib'],\n",
       " ['Other: Ascorbate', ''],\n",
       " ['Melphalan'],\n",
       " ['Biological: JNJ-68284528'],\n",
       " [''],\n",
       " ['Dara SC', ''],\n",
       " ['Dara IV'],\n",
       " [''],\n",
       " ['Carfilzomib', ''],\n",
       " ['Lenalidomide', ''],\n",
       " ['Dexamethasone', ''],\n",
       " ['Daratumumab', 'Procedure: autologous hematopoietic cell transplantation'],\n",
       " ['Biological: P-BCMA-101 CAR-T cells', ''],\n",
       " ['Rimiducid'],\n",
       " [''],\n",
       " ['Daratumumab Subcutaneous (SC) Administration', ''],\n",
       " ['Recombinant Human Hyaluronidase [rHuPH20]) SC Administration'],\n",
       " [''],\n",
       " ['MIK665'],\n",
       " [''],\n",
       " ['AMG 701'],\n",
       " [''],\n",
       " ['isatuximab SAR650984', ''],\n",
       " ['carfilzomib', ''],\n",
       " ['dexamethasone'],\n",
       " [''],\n",
       " ['GSK2857916 frozen', ''],\n",
       " ['GSK2857916 lyophilized',\n",
       "  'Other: NEI-VFQ-25 Questionnaire',\n",
       "  'Other: OSDI Questionnaire',\n",
       "  'Other: EORTC QLQ-C30 Questionnaire',\n",
       "  'Other: EORTC QLQ-MY20 Questionnaire'],\n",
       " ['Biological: bb21217'],\n",
       " ['Other: Laboratory Biomarker Analysis', ''],\n",
       " ['Melphalan Hydrochloride', 'Other: Pharmacological Study'],\n",
       " ['Biological: Kappa CD28 T cells'],\n",
       " [''],\n",
       " ['Dexamethasone', ''],\n",
       " ['Ixazomib', ''],\n",
       " ['Lenalidomide'],\n",
       " [''],\n",
       " ['Pralatrexate', ''],\n",
       " ['Romidepsin'],\n",
       " [''],\n",
       " ['Abemaciclib, dexamethasone, ixazomib, pomalidomide', ''],\n",
       " ['Enasidenib, dexamethasone, ixazomib, pomalidomide', ''],\n",
       " ['Cobimetinib, dexamethasone, ixazomib, pomalidomide', ''],\n",
       " ['Erdafitinib, dexamethasone, ixazomib, pomalidomide', ''],\n",
       " ['Venetoclax, dexamethasone, ixazomib, pomalidomide', ''],\n",
       " ['Daratumumab, dexamethasone, ixazomib, pomalidomide'],\n",
       " [''],\n",
       " ['Ixazomib Citrate', 'Other: Laboratory Biomarker Analysis', ''],\n",
       " ['Lenalidomide'],\n",
       " [''],\n",
       " ['Isatuximab'],\n",
       " [''],\n",
       " ['JNJ-64007957'],\n",
       " [''],\n",
       " ['JNJ-64407564'],\n",
       " [''],\n",
       " ['PDR001', ''],\n",
       " ['CJM112', ''],\n",
       " ['LCL161'],\n",
       " [''],\n",
       " ['Selinexor', ''],\n",
       " ['Bortezomib', ''],\n",
       " ['Dexamethasone'],\n",
       " [''],\n",
       " ['Melflufen', ''],\n",
       " ['Dexamethasone', ''],\n",
       " ['Bortezomib', ''],\n",
       " ['Daratumumab'],\n",
       " [''],\n",
       " ['SGN-CD48A'],\n",
       " [''],\n",
       " ['Isatuximab SAR650984', ''],\n",
       " ['Pomalidomide', ''],\n",
       " ['Dexamethasone'],\n",
       " [''],\n",
       " ['Treatment with TINOSTAMUSTINE'],\n",
       " [''],\n",
       " ['Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody', ''],\n",
       " ['Daratumumab', ''],\n",
       " ['Lenalidomide', ''],\n",
       " ['Pomalidomide', ''],\n",
       " ['Dexamethasone'],\n",
       " ['Biological: Nivolumab',\n",
       "  'Biological: Ipilimumab',\n",
       "  'Biological: Lirilumab',\n",
       "  'Biological: Daratumumab',\n",
       "  ''],\n",
       " ['Pomalidomide', ''],\n",
       " ['Dexamethasone'],\n",
       " [''],\n",
       " ['MEDI7247'],\n",
       " [''],\n",
       " ['NK cells +CliniMACs CD3 and CD56 systems', 'Biological: NK cells'],\n",
       " [''],\n",
       " ['KPT-8602'],\n",
       " ['Procedure: Allogeneic Bone Marrow Transplantation',\n",
       "  'Procedure: Allogeneic Hematopoietic Stem Cell Transplantation',\n",
       "  'Procedure: Autologous Hematopoietic Stem Cell Transplantation',\n",
       "  'Procedure: Autologous-Allogeneic Tandem Hematopoietic Stem Cell Transplantation',\n",
       "  ''],\n",
       " ['Carmustine', ''],\n",
       " ['Cyclophosphamide', ''],\n",
       " ['Cytarabine', ''],\n",
       " ['Etoposide', ''],\n",
       " ['Fludarabine Phosphate', 'Other: Laboratory Biomarker Analysis', ''],\n",
       " ['Melphalan', ''],\n",
       " ['Mycophenolate Mofetil',\n",
       "  'Procedure: Peripheral Blood Stem Cell Transplantation',\n",
       "  ''],\n",
       " ['Tacrolimus', 'Radiation: Total-Body Irradiation'],\n",
       " [''],\n",
       " ['busulfan', ''],\n",
       " ['cyclophosphamide',\n",
       "  'Biological: Stem cell infusion',\n",
       "  'Radiation: Total body irradiation'],\n",
       " [''],\n",
       " ['Adavosertib', ''],\n",
       " ['Afatinib', ''],\n",
       " ['Binimetinib', ''],\n",
       " ['Capivasertib', ''],\n",
       " ['Crizotinib', 'Other: Cytology Specimen Collection Procedure', ''],\n",
       " ['Dabrafenib', ''],\n",
       " ['Dasatinib', ''],\n",
       " ['Defactinib', ''],\n",
       " ['FGFR Inhibitor AZD4547', 'Other: Laboratory Biomarker Analysis', ''],\n",
       " ['Larotrectinib', 'Biological: Nivolumab', ''],\n",
       " ['Osimertinib', ''],\n",
       " ['Palbociclib', 'Biological: Pertuzumab', ''],\n",
       " ['PI3K-beta Inhibitor GSK2636771', ''],\n",
       " ['Sapanisertib', ''],\n",
       " ['Sunitinib Malate', ''],\n",
       " ['Taselisib', ''],\n",
       " ['Trametinib',\n",
       "  'Biological: Trastuzumab',\n",
       "  'Biological: Trastuzumab Emtansine',\n",
       "  ''],\n",
       " ['Vismodegib'],\n",
       " [''],\n",
       " ['AMG 397'],\n",
       " [''],\n",
       " ['RO6870810', 'Biological: daratumumab'],\n",
       " [''],\n",
       " ['EDO-S101'],\n",
       " [''],\n",
       " ['Nivolumab', ''],\n",
       " ['Tocilizumab'],\n",
       " ['Biological: NKR-2 cells'],\n",
       " [''],\n",
       " ['AZD5991'],\n",
       " [''],\n",
       " ['Dasatinib'],\n",
       " [''],\n",
       " ['CLR 131'],\n",
       " [''],\n",
       " ['Fludarabine',\n",
       "  'Radiation: Total-Body Irradiation',\n",
       "  'Biological: T Cell-Depleted Donor Lymphocyte Infusion',\n",
       "  ''],\n",
       " ['Cyclophosphamide',\n",
       "  'Procedure: Peripheral Blood Stem Cell Transplantation',\n",
       "  'Procedure: Allogeneic Hematopoietic Stem Cell Transplantation',\n",
       "  ''],\n",
       " ['Tacrolimus', ''],\n",
       " ['Mycophenolate mofetil'],\n",
       " [''],\n",
       " ['Fludarabine phosphate', ''],\n",
       " ['Thiotepa',\n",
       "  'Radiation: Total body irradiation',\n",
       "  'Biological: Therapeutic allogeneic lymphocytes',\n",
       "  ''],\n",
       " ['Cyclophosphamide',\n",
       "  'Procedure: Allogeneic hematopoietic stem cell transplantation (HSCT)',\n",
       "  'Procedure: Peripheral blood stem cell transplantation',\n",
       "  ''],\n",
       " ['Tacrolimus', ''],\n",
       " ['Mycophenolate mofetil'],\n",
       " [''],\n",
       " ['Fludarabine', ''],\n",
       " ['Busulfan',\n",
       "  'Radiation: Total Body Irradiation (TBI)',\n",
       "  'Biological: Donor Lymphocyte Infusion (DLI)',\n",
       "  ''],\n",
       " ['Cyclophosphamide (CY)', ''],\n",
       " ['Tacrolimus', ''],\n",
       " ['Mycophenolate mofetil',\n",
       "  'Device: Allogeneic hematopoietic stem cell transplantation',\n",
       "  'Procedure: Peripheral blood stem cell transplantation (PBSCT)'],\n",
       " ['Biological: HSCT with TBI Regimen',\n",
       "  'Biological: HSCT with Non-TBI Regimen'],\n",
       " [\"Device: 3'-deoxy-3'-[18F]fluorothymidine\"],\n",
       " [''],\n",
       " ['rhIL-2', 'Biological: PNK-007'],\n",
       " ['Procedure: Allogeneic Hematopoietic Stem Cell Transplantation',\n",
       "  'Biological: Irradiated Allogeneic Cells'],\n",
       " [''],\n",
       " ['Cyclophosphamide', 'Biological: Filgrastim', ''],\n",
       " ['Fludarabine Phosphate', 'Procedure: Laboratory Biomarker Analysis', ''],\n",
       " ['Mycophenolate Mofetil',\n",
       "  'Procedure: Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation',\n",
       "  'Procedure: Peripheral Blood Stem Cell Transplantation',\n",
       "  ''],\n",
       " ['Tacrolimus', 'Radiation: Total-Body Irradiation'],\n",
       " [''],\n",
       " ['Busulfan', ''],\n",
       " ['Cyclophosphamide', ''],\n",
       " ['Fludarabine Phosphate',\n",
       "  'Procedure: Hematopoietic Cell Transplantation',\n",
       "  'Other: Laboratory Biomarker Analysis',\n",
       "  ''],\n",
       " ['Melphalan Hydrochloride', ''],\n",
       " ['Mycophenolate Mofetil',\n",
       "  'Procedure: Peripheral Blood Stem Cell Transplantation',\n",
       "  'Other: Quality-of-Life Assessment',\n",
       "  ''],\n",
       " ['Tacrolimus', 'Radiation: Total-Body Irradiation'],\n",
       " [''],\n",
       " ['Dasatinib', 'Other: laboratory biomarker analysis'],\n",
       " [''],\n",
       " ['Cyclophosphamide', ''],\n",
       " ['Fludarabine Phosphate',\n",
       "  'Other: Laboratory Biomarker Analysis',\n",
       "  'Procedure: Peripheral Blood Stem Cell Transplantation',\n",
       "  'Radiation: Total-Body Irradiation'],\n",
       " [''],\n",
       " ['Cyclophosphamide', ''],\n",
       " ['Cyclosporine',\n",
       "  'Procedure: Double-Unit Umbilical Cord Blood Transplantation',\n",
       "  ''],\n",
       " ['Fludarabine Phosphate', 'Other: Laboratory Biomarker Analysis', ''],\n",
       " ['Mycophenolate Mofetil',\n",
       "  'Radiation: Total-Body Irradiation',\n",
       "  'Procedure: Umbilical Cord Blood Transplantation',\n",
       "  ''],\n",
       " ['Thiotepa'],\n",
       " [''],\n",
       " ['GSK525762'],\n",
       " ['Procedure: Allogeneic Hematopoietic Stem Cell Transplantation', ''],\n",
       " ['Cyclosporine', ''],\n",
       " ['Fludarabine Phosphate', 'Other: Laboratory Biomarker Analysis', ''],\n",
       " ['Mycophenolate Mofetil',\n",
       "  'Procedure: Peripheral Blood Stem Cell Transplantation',\n",
       "  ''],\n",
       " ['Sirolimus', 'Radiation: Total-Body Irradiation'],\n",
       " [''],\n",
       " ['INCB053914', ''],\n",
       " ['I-DAC (Intermediate dose cytarabine)', ''],\n",
       " ['Azacitidine', ''],\n",
       " ['Ruxolitinib']]"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "lst2=[]\n",
    "for i in range(len(lst)):\n",
    "    for j in range(len(lst[i])):\n",
    "        lst2.append(lst[i][j].split(b))\n",
    "    \n",
    "lst2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['',\n",
       " 'DS-3032b',\n",
       " '',\n",
       " 'ONC201',\n",
       " '',\n",
       " 'Ixazomib',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " 'Biological: bb2121',\n",
       " 'Biological: CAR2 Anti-CD38 A2 CAR-T Cells',\n",
       " '',\n",
       " 'Ixazomib',\n",
       " '',\n",
       " 'Pomalidomide',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'Daratumumab',\n",
       " '',\n",
       " 'SAR650984',\n",
       " '',\n",
       " 'Carfilzomib',\n",
       " '',\n",
       " 'Cabozantinib',\n",
       " '',\n",
       " 'bb2121',\n",
       " '',\n",
       " 'Daratumumab',\n",
       " '',\n",
       " 'Pomalidomide',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'Bortezomib',\n",
       " '',\n",
       " 'Ixazomib',\n",
       " '',\n",
       " 'Lenalidomide',\n",
       " 'Other: Laboratory Biomarker Analysis',\n",
       " '',\n",
       " 'Lenalidomide',\n",
       " 'Biological: Nivolumab',\n",
       " 'Other: Pharmacological Study',\n",
       " '',\n",
       " 'Bortezomib',\n",
       " 'Biological: Daratumumab',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'Ixazomib',\n",
       " 'Other: Quality-of-Life Assessment',\n",
       " '',\n",
       " 'Carfilzomib',\n",
       " 'Other: Chemosensitivity Assay',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " 'Other: Laboratory Biomarker Analysis',\n",
       " '',\n",
       " 'Panobinostat',\n",
       " '',\n",
       " 'ABC294640',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " 'Biological: Elotuzumab',\n",
       " '',\n",
       " 'Pomalidomide',\n",
       " '',\n",
       " 'ONC201',\n",
       " 'Procedure: Autologous Hematopoietic Stem Cell Transplantation',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'Ixazomib Citrate',\n",
       " 'Other: Laboratory Biomarker Analysis',\n",
       " '',\n",
       " 'Pomalidomide',\n",
       " '',\n",
       " 'GSK2857916',\n",
       " '',\n",
       " 'Lenalidomide',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'Bortezomib',\n",
       " '',\n",
       " 'RP2D of GSK2857916',\n",
       " '',\n",
       " 'Lintuzumab AC 225',\n",
       " '',\n",
       " 'ABI-009',\n",
       " '',\n",
       " 'Pomalidomide',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " 'Procedure: Biospecimen Collection',\n",
       " 'Device: High Throughput Screening',\n",
       " 'Other: Laboratory Biomarker Analysis',\n",
       " '',\n",
       " 'CAR138 T Cells',\n",
       " '',\n",
       " 'Elotuzumab',\n",
       " 'Procedure: Autologous Hematopoietic Stem Cell Transplantation',\n",
       " '',\n",
       " 'Busulfan',\n",
       " '',\n",
       " 'Gemcitabine Hydrochloride',\n",
       " 'Other: Laboratory Biomarker Analysis',\n",
       " '',\n",
       " 'Melphalan',\n",
       " '',\n",
       " 'Panobinostat',\n",
       " 'Procedure: Peripheral Blood Stem Cell Transplantation',\n",
       " 'Other: Pharmacological Study',\n",
       " 'Procedure: Guided Lesion Biopsies',\n",
       " 'Procedure: Standard Lesion Biopsies',\n",
       " '',\n",
       " 'Dabrafenib',\n",
       " '',\n",
       " 'Trametinib',\n",
       " '',\n",
       " 'Carfilzomib',\n",
       " '',\n",
       " 'Ruxolitinib',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'Blinatumomab',\n",
       " '',\n",
       " 'MV-NIS',\n",
       " 'Procedure: CS1-CAR T Therapy',\n",
       " '',\n",
       " 'Cyclophosphamide',\n",
       " '',\n",
       " 'Fludarabine',\n",
       " 'Procedure: Leukapheresis',\n",
       " '',\n",
       " 'Cyclophosphamide',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'Ixazomib Citrate',\n",
       " 'Other: Laboratory Biomarker Analysis',\n",
       " '',\n",
       " 'TEW-7197',\n",
       " '',\n",
       " 'Pomalidomide',\n",
       " '',\n",
       " 'SL-401/ Pomalidomide/ Dexamethasone',\n",
       " 'Biological: Pembrolizumab',\n",
       " 'Radiation: Radiation Therapy',\n",
       " 'Biological: Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143',\n",
       " '',\n",
       " 'Cyclophosphamide',\n",
       " '',\n",
       " 'Fludarabine',\n",
       " 'Other: Laboratory Biomarker Analysis',\n",
       " 'Procedure: Leukapheresis',\n",
       " '',\n",
       " 'I-131-CLR1404',\n",
       " '',\n",
       " 'dexamethasone',\n",
       " 'Biological: ACTR087',\n",
       " 'Biological: SEA-BCMA',\n",
       " '',\n",
       " 'ACE-011',\n",
       " '',\n",
       " 'Lenalidomide',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'Pomalidomide',\n",
       " '',\n",
       " 'TAK-573',\n",
       " '',\n",
       " 'TTI-622 Monotherapy',\n",
       " '',\n",
       " 'TTI-622 + Rituximab',\n",
       " '',\n",
       " 'TTI-622 + PD-1/PD-L1 Inhibitor',\n",
       " '',\n",
       " 'TTI-622 + Proteasome-inhibitor Regimen',\n",
       " 'Radiation: 18F-FHBG',\n",
       " 'Biological: Aldesleukin',\n",
       " 'Biological: Cellular Therapy',\n",
       " 'Procedure: Computed Tomography',\n",
       " 'Biological: Filgrastim',\n",
       " 'Other: Laboratory Biomarker Analysis',\n",
       " '',\n",
       " 'Lenalidomide',\n",
       " 'Procedure: Leukapheresis',\n",
       " '',\n",
       " 'Melphalan',\n",
       " '',\n",
       " 'Plerixafor',\n",
       " 'Procedure: Positron Emission Tomography',\n",
       " '',\n",
       " 'AMG 424',\n",
       " '',\n",
       " 'Carfilzomib',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " 'Biological: Nivolumab',\n",
       " 'Biological: Wild-type Reovirus',\n",
       " '',\n",
       " 'selinexor',\n",
       " '',\n",
       " 'carfilzomib',\n",
       " '',\n",
       " 'dexamethasone',\n",
       " 'Biological: Abatacept',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'Ixazomib Citrate',\n",
       " 'Other: Laboratory Biomarker Analysis',\n",
       " 'Biological: BCMA-specific CAR-expressing T Lymphocytes',\n",
       " '',\n",
       " 'Cyclophosphamide',\n",
       " '',\n",
       " 'Fludarabine',\n",
       " '',\n",
       " 'Gamma-Secretase Inhibitor LY3039478',\n",
       " 'Other: Laboratory Biomarker Analysis',\n",
       " 'Other: Pharmacokinetic Study',\n",
       " '',\n",
       " 'SEA-BCMA',\n",
       " 'Combination Product: BCMA CART + huCART19',\n",
       " 'Combination Product: CART BCMA or CART BCMA + huCART19',\n",
       " 'Combination Product: Single-dose infusion of CART BCMA or CART BCMA + huCART19',\n",
       " '',\n",
       " 'Pomalidomide',\n",
       " '',\n",
       " 'Carfilzomib',\n",
       " '',\n",
       " 'dexamethasone',\n",
       " '',\n",
       " 'Daratumumab',\n",
       " '',\n",
       " 'Phase 1a: CWP232291',\n",
       " '',\n",
       " 'Phase 1b: CWP232291, Lenalidomide, Dexamethasone',\n",
       " 'Radiation: Total Body Irradiation',\n",
       " 'Procedure: Haploidentical Stem Cell Transplantation',\n",
       " 'Biological: CD56-Enriched Donor Lymphocyte Infusion',\n",
       " '',\n",
       " 'Bendamustine',\n",
       " '',\n",
       " 'Fludarabine',\n",
       " '',\n",
       " 'Rituximab',\n",
       " 'Biological: Dose Escalation, MEDI2228, ADC (antibody drug conjugate)',\n",
       " 'Biological: Dose Expansion, MEDI2228, ADC (antibody drug conjugate)',\n",
       " 'Genetic: NY-ESO-1ᶜ²⁵⁹T cells',\n",
       " '',\n",
       " 'NY-ESO-1ᶜ²⁵⁹T in combination with pembrolizumab',\n",
       " '',\n",
       " 'Immediate Release (IR) Formulation',\n",
       " '',\n",
       " 'Gastro-Retentive (GR) Formulation',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'Pomalidomide',\n",
       " '',\n",
       " 'Clarithromycin',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'Ixazomib Citrate',\n",
       " '',\n",
       " 'Pomalidomide',\n",
       " '',\n",
       " 'PT-112',\n",
       " '',\n",
       " 'Carfilzomib',\n",
       " '',\n",
       " 'Venetoclax',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'Melflufen',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " 'Combination Product: Dexamethasone',\n",
       " 'Combination Product: Carfilzomib',\n",
       " '',\n",
       " 'Ixazomib',\n",
       " '',\n",
       " 'Pomalidomide',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'Elotuzumab',\n",
       " '',\n",
       " 'Pomalidomide',\n",
       " '',\n",
       " 'Carfilzomib',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'POM',\n",
       " '',\n",
       " 'Steroids',\n",
       " '',\n",
       " 'PLD',\n",
       " '',\n",
       " 'CFZ',\n",
       " '',\n",
       " 'BTZ',\n",
       " '',\n",
       " 'CLA',\n",
       " '',\n",
       " 'Other drugs',\n",
       " '',\n",
       " 'CY',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'ABT-199',\n",
       " '',\n",
       " 'Pomalidomide',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'Venetoclax',\n",
       " '',\n",
       " 'Carfilzomib',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'Prednisone',\n",
       " '',\n",
       " 'Methylprednisolone',\n",
       " '',\n",
       " 'Lenalidomide',\n",
       " '',\n",
       " 'Pomalidomide',\n",
       " '',\n",
       " 'Elotuzumab',\n",
       " '',\n",
       " 'Pomalidomide',\n",
       " '',\n",
       " 'Bortezomib',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'Daratumumab',\n",
       " '',\n",
       " 'Venetoclax',\n",
       " '',\n",
       " 'Bortezomib',\n",
       " '',\n",
       " 'CC-93269',\n",
       " 'Genetic: Autologous genetically modified anti-BCMA CAR transduced T cells (KITE-585)',\n",
       " '',\n",
       " 'Cyclophosphamide',\n",
       " '',\n",
       " 'Fludarabine',\n",
       " '',\n",
       " 'PF-06863135',\n",
       " '',\n",
       " 'CC-92480',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'Venetoclax',\n",
       " '',\n",
       " 'Pomalidomide',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'AMG 176',\n",
       " 'Biological: JCARH125',\n",
       " 'Biological: BION-1301',\n",
       " '',\n",
       " 'Ixazomib',\n",
       " '',\n",
       " 'Daratumumab',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'BFCR4350A',\n",
       " '',\n",
       " 'TAK-079',\n",
       " 'Biological: Nicotinamide Expanded Haploidentical or Mismatched Related Donor Natural Killer Cells',\n",
       " '',\n",
       " 'Carfilzomib',\n",
       " '',\n",
       " 'Pomalidomide',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'Melflufen',\n",
       " '',\n",
       " 'Pomalidomide',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'Ruxolitinib Oral Tablet [Jakafi]',\n",
       " '',\n",
       " 'Lenalidomide 5Mg Oral Capsule',\n",
       " '',\n",
       " 'Methyl Prednisolonate',\n",
       " '',\n",
       " 'Isatuximab SAR650984',\n",
       " '',\n",
       " 'Cemiplimab REGN2810',\n",
       " '',\n",
       " 'Elotuzumab',\n",
       " '',\n",
       " 'Pomalidomide',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " 'Procedure: Autologous stem cell transplant',\n",
       " '',\n",
       " 'Melphalan',\n",
       " 'Biological: Pembrolizumab',\n",
       " 'Biological: Daratumumab',\n",
       " '',\n",
       " 'Selinexor',\n",
       " '',\n",
       " 'Ixazomib',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'panobinostat capsules',\n",
       " '',\n",
       " 'bortezomib injection',\n",
       " '',\n",
       " 'dexamethasone tablets',\n",
       " '',\n",
       " 'CC-220',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'Daratumumab',\n",
       " '',\n",
       " 'Bortezomib (BTZ)',\n",
       " '',\n",
       " 'Selinexor',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'Lenalidomide',\n",
       " '',\n",
       " 'Pomalidomide',\n",
       " '',\n",
       " 'Bortezomib',\n",
       " '',\n",
       " 'Daratumumab',\n",
       " '',\n",
       " 'Carfilzomib',\n",
       " 'Other: Ascorbate',\n",
       " '',\n",
       " 'Melphalan',\n",
       " 'Biological: JNJ-68284528',\n",
       " '',\n",
       " 'Dara SC',\n",
       " '',\n",
       " 'Dara IV',\n",
       " '',\n",
       " 'Carfilzomib',\n",
       " '',\n",
       " 'Lenalidomide',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'Daratumumab',\n",
       " 'Procedure: autologous hematopoietic cell transplantation',\n",
       " 'Biological: P-BCMA-101 CAR-T cells',\n",
       " '',\n",
       " 'Rimiducid',\n",
       " '',\n",
       " 'Daratumumab Subcutaneous (SC) Administration',\n",
       " '',\n",
       " 'Recombinant Human Hyaluronidase [rHuPH20]) SC Administration',\n",
       " '',\n",
       " 'MIK665',\n",
       " '',\n",
       " 'AMG 701',\n",
       " '',\n",
       " 'isatuximab SAR650984',\n",
       " '',\n",
       " 'carfilzomib',\n",
       " '',\n",
       " 'dexamethasone',\n",
       " '',\n",
       " 'GSK2857916 frozen',\n",
       " '',\n",
       " 'GSK2857916 lyophilized',\n",
       " 'Other: NEI-VFQ-25 Questionnaire',\n",
       " 'Other: OSDI Questionnaire',\n",
       " 'Other: EORTC QLQ-C30 Questionnaire',\n",
       " 'Other: EORTC QLQ-MY20 Questionnaire',\n",
       " 'Biological: bb21217',\n",
       " 'Other: Laboratory Biomarker Analysis',\n",
       " '',\n",
       " 'Melphalan Hydrochloride',\n",
       " 'Other: Pharmacological Study',\n",
       " 'Biological: Kappa CD28 T cells',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'Ixazomib',\n",
       " '',\n",
       " 'Lenalidomide',\n",
       " '',\n",
       " 'Pralatrexate',\n",
       " '',\n",
       " 'Romidepsin',\n",
       " '',\n",
       " 'Abemaciclib, dexamethasone, ixazomib, pomalidomide',\n",
       " '',\n",
       " 'Enasidenib, dexamethasone, ixazomib, pomalidomide',\n",
       " '',\n",
       " 'Cobimetinib, dexamethasone, ixazomib, pomalidomide',\n",
       " '',\n",
       " 'Erdafitinib, dexamethasone, ixazomib, pomalidomide',\n",
       " '',\n",
       " 'Venetoclax, dexamethasone, ixazomib, pomalidomide',\n",
       " '',\n",
       " 'Daratumumab, dexamethasone, ixazomib, pomalidomide',\n",
       " '',\n",
       " 'Ixazomib Citrate',\n",
       " 'Other: Laboratory Biomarker Analysis',\n",
       " '',\n",
       " 'Lenalidomide',\n",
       " '',\n",
       " 'Isatuximab',\n",
       " '',\n",
       " 'JNJ-64007957',\n",
       " '',\n",
       " 'JNJ-64407564',\n",
       " '',\n",
       " 'PDR001',\n",
       " '',\n",
       " 'CJM112',\n",
       " '',\n",
       " 'LCL161',\n",
       " '',\n",
       " 'Selinexor',\n",
       " '',\n",
       " 'Bortezomib',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'Melflufen',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'Bortezomib',\n",
       " '',\n",
       " 'Daratumumab',\n",
       " '',\n",
       " 'SGN-CD48A',\n",
       " '',\n",
       " 'Isatuximab SAR650984',\n",
       " '',\n",
       " 'Pomalidomide',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'Treatment with TINOSTAMUSTINE',\n",
       " '',\n",
       " 'Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody',\n",
       " '',\n",
       " 'Daratumumab',\n",
       " '',\n",
       " 'Lenalidomide',\n",
       " '',\n",
       " 'Pomalidomide',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " 'Biological: Nivolumab',\n",
       " 'Biological: Ipilimumab',\n",
       " 'Biological: Lirilumab',\n",
       " 'Biological: Daratumumab',\n",
       " '',\n",
       " 'Pomalidomide',\n",
       " '',\n",
       " 'Dexamethasone',\n",
       " '',\n",
       " 'MEDI7247',\n",
       " '',\n",
       " 'NK cells +CliniMACs CD3 and CD56 systems',\n",
       " 'Biological: NK cells',\n",
       " '',\n",
       " 'KPT-8602',\n",
       " 'Procedure: Allogeneic Bone Marrow Transplantation',\n",
       " 'Procedure: Allogeneic Hematopoietic Stem Cell Transplantation',\n",
       " 'Procedure: Autologous Hematopoietic Stem Cell Transplantation',\n",
       " 'Procedure: Autologous-Allogeneic Tandem Hematopoietic Stem Cell Transplantation',\n",
       " '',\n",
       " 'Carmustine',\n",
       " '',\n",
       " 'Cyclophosphamide',\n",
       " '',\n",
       " 'Cytarabine',\n",
       " '',\n",
       " 'Etoposide',\n",
       " '',\n",
       " 'Fludarabine Phosphate',\n",
       " 'Other: Laboratory Biomarker Analysis',\n",
       " '',\n",
       " 'Melphalan',\n",
       " '',\n",
       " 'Mycophenolate Mofetil',\n",
       " 'Procedure: Peripheral Blood Stem Cell Transplantation',\n",
       " '',\n",
       " 'Tacrolimus',\n",
       " 'Radiation: Total-Body Irradiation',\n",
       " '',\n",
       " 'busulfan',\n",
       " '',\n",
       " 'cyclophosphamide',\n",
       " 'Biological: Stem cell infusion',\n",
       " 'Radiation: Total body irradiation',\n",
       " '',\n",
       " 'Adavosertib',\n",
       " '',\n",
       " 'Afatinib',\n",
       " '',\n",
       " 'Binimetinib',\n",
       " '',\n",
       " 'Capivasertib',\n",
       " '',\n",
       " 'Crizotinib',\n",
       " 'Other: Cytology Specimen Collection Procedure',\n",
       " '',\n",
       " 'Dabrafenib',\n",
       " '',\n",
       " 'Dasatinib',\n",
       " '',\n",
       " 'Defactinib',\n",
       " '',\n",
       " 'FGFR Inhibitor AZD4547',\n",
       " 'Other: Laboratory Biomarker Analysis',\n",
       " '',\n",
       " 'Larotrectinib',\n",
       " 'Biological: Nivolumab',\n",
       " '',\n",
       " 'Osimertinib',\n",
       " '',\n",
       " 'Palbociclib',\n",
       " 'Biological: Pertuzumab',\n",
       " '',\n",
       " 'PI3K-beta Inhibitor GSK2636771',\n",
       " '',\n",
       " 'Sapanisertib',\n",
       " '',\n",
       " 'Sunitinib Malate',\n",
       " '',\n",
       " 'Taselisib',\n",
       " '',\n",
       " 'Trametinib',\n",
       " 'Biological: Trastuzumab',\n",
       " 'Biological: Trastuzumab Emtansine',\n",
       " '',\n",
       " 'Vismodegib',\n",
       " '',\n",
       " 'AMG 397',\n",
       " '',\n",
       " 'RO6870810',\n",
       " 'Biological: daratumumab',\n",
       " '',\n",
       " 'EDO-S101',\n",
       " '',\n",
       " 'Nivolumab',\n",
       " '',\n",
       " 'Tocilizumab',\n",
       " 'Biological: NKR-2 cells',\n",
       " '',\n",
       " 'AZD5991',\n",
       " '',\n",
       " 'Dasatinib',\n",
       " '',\n",
       " 'CLR 131',\n",
       " '',\n",
       " 'Fludarabine',\n",
       " 'Radiation: Total-Body Irradiation',\n",
       " 'Biological: T Cell-Depleted Donor Lymphocyte Infusion',\n",
       " '',\n",
       " 'Cyclophosphamide',\n",
       " 'Procedure: Peripheral Blood Stem Cell Transplantation',\n",
       " 'Procedure: Allogeneic Hematopoietic Stem Cell Transplantation',\n",
       " '',\n",
       " 'Tacrolimus',\n",
       " '',\n",
       " 'Mycophenolate mofetil',\n",
       " '',\n",
       " 'Fludarabine phosphate',\n",
       " '',\n",
       " 'Thiotepa',\n",
       " 'Radiation: Total body irradiation',\n",
       " 'Biological: Therapeutic allogeneic lymphocytes',\n",
       " '',\n",
       " 'Cyclophosphamide',\n",
       " 'Procedure: Allogeneic hematopoietic stem cell transplantation (HSCT)',\n",
       " 'Procedure: Peripheral blood stem cell transplantation',\n",
       " '',\n",
       " 'Tacrolimus',\n",
       " '',\n",
       " 'Mycophenolate mofetil',\n",
       " '',\n",
       " 'Fludarabine',\n",
       " '',\n",
       " 'Busulfan',\n",
       " 'Radiation: Total Body Irradiation (TBI)',\n",
       " 'Biological: Donor Lymphocyte Infusion (DLI)',\n",
       " '',\n",
       " 'Cyclophosphamide (CY)',\n",
       " '',\n",
       " 'Tacrolimus',\n",
       " '',\n",
       " 'Mycophenolate mofetil',\n",
       " 'Device: Allogeneic hematopoietic stem cell transplantation',\n",
       " 'Procedure: Peripheral blood stem cell transplantation (PBSCT)',\n",
       " 'Biological: HSCT with TBI Regimen',\n",
       " 'Biological: HSCT with Non-TBI Regimen',\n",
       " \"Device: 3'-deoxy-3'-[18F]fluorothymidine\",\n",
       " '',\n",
       " 'rhIL-2',\n",
       " 'Biological: PNK-007',\n",
       " 'Procedure: Allogeneic Hematopoietic Stem Cell Transplantation',\n",
       " 'Biological: Irradiated Allogeneic Cells',\n",
       " '',\n",
       " 'Cyclophosphamide',\n",
       " 'Biological: Filgrastim',\n",
       " '',\n",
       " 'Fludarabine Phosphate',\n",
       " 'Procedure: Laboratory Biomarker Analysis',\n",
       " '',\n",
       " 'Mycophenolate Mofetil',\n",
       " 'Procedure: Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation',\n",
       " 'Procedure: Peripheral Blood Stem Cell Transplantation',\n",
       " '',\n",
       " 'Tacrolimus',\n",
       " 'Radiation: Total-Body Irradiation',\n",
       " '',\n",
       " 'Busulfan',\n",
       " '',\n",
       " 'Cyclophosphamide',\n",
       " '',\n",
       " 'Fludarabine Phosphate',\n",
       " 'Procedure: Hematopoietic Cell Transplantation',\n",
       " 'Other: Laboratory Biomarker Analysis',\n",
       " '',\n",
       " 'Melphalan Hydrochloride',\n",
       " '',\n",
       " 'Mycophenolate Mofetil',\n",
       " 'Procedure: Peripheral Blood Stem Cell Transplantation',\n",
       " 'Other: Quality-of-Life Assessment',\n",
       " '',\n",
       " 'Tacrolimus',\n",
       " 'Radiation: Total-Body Irradiation',\n",
       " '',\n",
       " 'Dasatinib',\n",
       " 'Other: laboratory biomarker analysis',\n",
       " '',\n",
       " 'Cyclophosphamide',\n",
       " '',\n",
       " 'Fludarabine Phosphate',\n",
       " 'Other: Laboratory Biomarker Analysis',\n",
       " 'Procedure: Peripheral Blood Stem Cell Transplantation',\n",
       " 'Radiation: Total-Body Irradiation',\n",
       " '',\n",
       " 'Cyclophosphamide',\n",
       " '',\n",
       " 'Cyclosporine',\n",
       " 'Procedure: Double-Unit Umbilical Cord Blood Transplantation',\n",
       " '',\n",
       " 'Fludarabine Phosphate',\n",
       " 'Other: Laboratory Biomarker Analysis',\n",
       " '',\n",
       " 'Mycophenolate Mofetil',\n",
       " 'Radiation: Total-Body Irradiation',\n",
       " 'Procedure: Umbilical Cord Blood Transplantation',\n",
       " '',\n",
       " 'Thiotepa',\n",
       " '',\n",
       " 'GSK525762',\n",
       " 'Procedure: Allogeneic Hematopoietic Stem Cell Transplantation',\n",
       " '',\n",
       " 'Cyclosporine',\n",
       " '',\n",
       " 'Fludarabine Phosphate',\n",
       " 'Other: Laboratory Biomarker Analysis',\n",
       " '',\n",
       " 'Mycophenolate Mofetil',\n",
       " 'Procedure: Peripheral Blood Stem Cell Transplantation',\n",
       " '',\n",
       " 'Sirolimus',\n",
       " 'Radiation: Total-Body Irradiation',\n",
       " '',\n",
       " 'INCB053914',\n",
       " '',\n",
       " 'I-DAC (Intermediate dose cytarabine)',\n",
       " '',\n",
       " 'Azacitidine',\n",
       " '',\n",
       " 'Ruxolitinib']"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "lst3=[]\n",
    "\n",
    "for i in range(len(lst2)):\n",
    "    for j in range(len(lst2[i])):\n",
    "        lst3.append(lst2[i][j])\n",
    "\n",
    "lst3"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(438, 238)"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "lst4=[]\n",
    "for i in range(len(lst3)):\n",
    "    if lst3[i] != '' and lst3[i][:5] != 'Other':\n",
    "        lst4.append(lst3[i])\n",
    "\n",
    "\n",
    "len(lst4), len(list(set(lst4)))    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Medication</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>DS-3032b</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>ONC201</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Ixazomib</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Dexamethasone</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Biological: bb2121</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Biological: CAR2 Anti-CD38 A2 CAR-T Cells</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Ixazomib</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Pomalidomide</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Dexamethasone</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Daratumumab</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>SAR650984</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Carfilzomib</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Cabozantinib</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>bb2121</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Daratumumab</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Pomalidomide</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>Dexamethasone</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Bortezomib</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>Ixazomib</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>Lenalidomide</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>Lenalidomide</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>Biological: Nivolumab</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>Bortezomib</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>Biological: Daratumumab</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>Dexamethasone</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>Ixazomib</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>Carfilzomib</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>Dexamethasone</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>Panobinostat</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>ABC294640</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>408</th>\n",
       "      <td>Melphalan Hydrochloride</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>409</th>\n",
       "      <td>Mycophenolate Mofetil</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>410</th>\n",
       "      <td>Procedure: Peripheral Blood Stem Cell Transpla...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>411</th>\n",
       "      <td>Tacrolimus</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>412</th>\n",
       "      <td>Radiation: Total-Body Irradiation</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>413</th>\n",
       "      <td>Dasatinib</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>414</th>\n",
       "      <td>Cyclophosphamide</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>415</th>\n",
       "      <td>Fludarabine Phosphate</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>416</th>\n",
       "      <td>Procedure: Peripheral Blood Stem Cell Transpla...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>417</th>\n",
       "      <td>Radiation: Total-Body Irradiation</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>418</th>\n",
       "      <td>Cyclophosphamide</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>419</th>\n",
       "      <td>Cyclosporine</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>420</th>\n",
       "      <td>Procedure: Double-Unit Umbilical Cord Blood Tr...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>421</th>\n",
       "      <td>Fludarabine Phosphate</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>422</th>\n",
       "      <td>Mycophenolate Mofetil</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>423</th>\n",
       "      <td>Radiation: Total-Body Irradiation</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>424</th>\n",
       "      <td>Procedure: Umbilical Cord Blood Transplantation</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>425</th>\n",
       "      <td>Thiotepa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>426</th>\n",
       "      <td>GSK525762</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>427</th>\n",
       "      <td>Procedure: Allogeneic Hematopoietic Stem Cell ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>428</th>\n",
       "      <td>Cyclosporine</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>429</th>\n",
       "      <td>Fludarabine Phosphate</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>430</th>\n",
       "      <td>Mycophenolate Mofetil</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>431</th>\n",
       "      <td>Procedure: Peripheral Blood Stem Cell Transpla...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>432</th>\n",
       "      <td>Sirolimus</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>433</th>\n",
       "      <td>Radiation: Total-Body Irradiation</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>434</th>\n",
       "      <td>INCB053914</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>435</th>\n",
       "      <td>I-DAC (Intermediate dose cytarabine)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>436</th>\n",
       "      <td>Azacitidine</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>437</th>\n",
       "      <td>Ruxolitinib</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>438 rows × 1 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                            Medication\n",
       "0                                             DS-3032b\n",
       "1                                               ONC201\n",
       "2                                             Ixazomib\n",
       "3                                        Dexamethasone\n",
       "4                                   Biological: bb2121\n",
       "5            Biological: CAR2 Anti-CD38 A2 CAR-T Cells\n",
       "6                                             Ixazomib\n",
       "7                                         Pomalidomide\n",
       "8                                        Dexamethasone\n",
       "9                                          Daratumumab\n",
       "10                                           SAR650984\n",
       "11                                         Carfilzomib\n",
       "12                                        Cabozantinib\n",
       "13                                              bb2121\n",
       "14                                         Daratumumab\n",
       "15                                        Pomalidomide\n",
       "16                                       Dexamethasone\n",
       "17                                          Bortezomib\n",
       "18                                            Ixazomib\n",
       "19                                        Lenalidomide\n",
       "20                                        Lenalidomide\n",
       "21                               Biological: Nivolumab\n",
       "22                                          Bortezomib\n",
       "23                             Biological: Daratumumab\n",
       "24                                       Dexamethasone\n",
       "25                                            Ixazomib\n",
       "26                                         Carfilzomib\n",
       "27                                       Dexamethasone\n",
       "28                                        Panobinostat\n",
       "29                                           ABC294640\n",
       "..                                                 ...\n",
       "408                            Melphalan Hydrochloride\n",
       "409                              Mycophenolate Mofetil\n",
       "410  Procedure: Peripheral Blood Stem Cell Transpla...\n",
       "411                                         Tacrolimus\n",
       "412                  Radiation: Total-Body Irradiation\n",
       "413                                          Dasatinib\n",
       "414                                   Cyclophosphamide\n",
       "415                              Fludarabine Phosphate\n",
       "416  Procedure: Peripheral Blood Stem Cell Transpla...\n",
       "417                  Radiation: Total-Body Irradiation\n",
       "418                                   Cyclophosphamide\n",
       "419                                       Cyclosporine\n",
       "420  Procedure: Double-Unit Umbilical Cord Blood Tr...\n",
       "421                              Fludarabine Phosphate\n",
       "422                              Mycophenolate Mofetil\n",
       "423                  Radiation: Total-Body Irradiation\n",
       "424    Procedure: Umbilical Cord Blood Transplantation\n",
       "425                                           Thiotepa\n",
       "426                                          GSK525762\n",
       "427  Procedure: Allogeneic Hematopoietic Stem Cell ...\n",
       "428                                       Cyclosporine\n",
       "429                              Fludarabine Phosphate\n",
       "430                              Mycophenolate Mofetil\n",
       "431  Procedure: Peripheral Blood Stem Cell Transpla...\n",
       "432                                          Sirolimus\n",
       "433                  Radiation: Total-Body Irradiation\n",
       "434                                         INCB053914\n",
       "435               I-DAC (Intermediate dose cytarabine)\n",
       "436                                        Azacitidine\n",
       "437                                        Ruxolitinib\n",
       "\n",
       "[438 rows x 1 columns]"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "Medication = pd.DataFrame(lst4) \n",
    "Medication.columns = ['Medication']\n",
    "Medication"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package punkt to /home/probinso/nltk_data...\n",
      "[nltk_data]   Unzipping tokenizers/punkt.zip.\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import nltk\n",
    "#nltk.download('punkt')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [],
   "source": [
    "words = []\n",
    "for i in range(len(lst4)):\n",
    "    temp = nltk.tokenize.word_tokenize(lst4[i])\n",
    "    words.append(temp)\n",
    "    \n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [],
   "source": [
    "word_lst = []\n",
    "for i in range(len(words)):\n",
    "    for j in range(len(words[i])):\n",
    "        word_lst.append(words[i][j])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['DS-3032b',\n",
       " 'ONC201',\n",
       " 'Ixazomib',\n",
       " 'Dexamethasone',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'bb2121',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'CAR2',\n",
       " 'Anti-CD38',\n",
       " 'A2',\n",
       " 'CAR-T',\n",
       " 'Cells',\n",
       " 'Ixazomib',\n",
       " 'Pomalidomide',\n",
       " 'Dexamethasone',\n",
       " 'Daratumumab',\n",
       " 'SAR650984',\n",
       " 'Carfilzomib',\n",
       " 'Cabozantinib',\n",
       " 'bb2121',\n",
       " 'Daratumumab',\n",
       " 'Pomalidomide',\n",
       " 'Dexamethasone',\n",
       " 'Bortezomib',\n",
       " 'Ixazomib',\n",
       " 'Lenalidomide',\n",
       " 'Lenalidomide',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Nivolumab',\n",
       " 'Bortezomib',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Daratumumab',\n",
       " 'Dexamethasone',\n",
       " 'Ixazomib',\n",
       " 'Carfilzomib',\n",
       " 'Dexamethasone',\n",
       " 'Panobinostat',\n",
       " 'ABC294640',\n",
       " 'Dexamethasone',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Elotuzumab',\n",
       " 'Pomalidomide',\n",
       " 'ONC201',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Autologous',\n",
       " 'Hematopoietic',\n",
       " 'Stem',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Dexamethasone',\n",
       " 'Ixazomib',\n",
       " 'Citrate',\n",
       " 'Pomalidomide',\n",
       " 'GSK2857916',\n",
       " 'Lenalidomide',\n",
       " 'Dexamethasone',\n",
       " 'Bortezomib',\n",
       " 'RP2D',\n",
       " 'of',\n",
       " 'GSK2857916',\n",
       " 'Lintuzumab',\n",
       " 'AC',\n",
       " '225',\n",
       " 'ABI-009',\n",
       " 'Pomalidomide',\n",
       " 'Dexamethasone',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Biospecimen',\n",
       " 'Collection',\n",
       " 'Device',\n",
       " ':',\n",
       " 'High',\n",
       " 'Throughput',\n",
       " 'Screening',\n",
       " 'CAR138',\n",
       " 'T',\n",
       " 'Cells',\n",
       " 'Elotuzumab',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Autologous',\n",
       " 'Hematopoietic',\n",
       " 'Stem',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Busulfan',\n",
       " 'Gemcitabine',\n",
       " 'Hydrochloride',\n",
       " 'Melphalan',\n",
       " 'Panobinostat',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Peripheral',\n",
       " 'Blood',\n",
       " 'Stem',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Guided',\n",
       " 'Lesion',\n",
       " 'Biopsies',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Standard',\n",
       " 'Lesion',\n",
       " 'Biopsies',\n",
       " 'Dabrafenib',\n",
       " 'Trametinib',\n",
       " 'Carfilzomib',\n",
       " 'Ruxolitinib',\n",
       " 'Dexamethasone',\n",
       " 'Blinatumomab',\n",
       " 'MV-NIS',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'CS1-CAR',\n",
       " 'T',\n",
       " 'Therapy',\n",
       " 'Cyclophosphamide',\n",
       " 'Fludarabine',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Leukapheresis',\n",
       " 'Cyclophosphamide',\n",
       " 'Dexamethasone',\n",
       " 'Ixazomib',\n",
       " 'Citrate',\n",
       " 'TEW-7197',\n",
       " 'Pomalidomide',\n",
       " 'SL-401/',\n",
       " 'Pomalidomide/',\n",
       " 'Dexamethasone',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Pembrolizumab',\n",
       " 'Radiation',\n",
       " ':',\n",
       " 'Radiation',\n",
       " 'Therapy',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Autologous',\n",
       " 'Anti-BCMA-CAR-expressing',\n",
       " 'CD4+/CD8+',\n",
       " 'T-lymphocytes',\n",
       " 'FCARH143',\n",
       " 'Cyclophosphamide',\n",
       " 'Fludarabine',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Leukapheresis',\n",
       " 'I-131-CLR1404',\n",
       " 'dexamethasone',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'ACTR087',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'SEA-BCMA',\n",
       " 'ACE-011',\n",
       " 'Lenalidomide',\n",
       " 'Dexamethasone',\n",
       " 'Pomalidomide',\n",
       " 'TAK-573',\n",
       " 'TTI-622',\n",
       " 'Monotherapy',\n",
       " 'TTI-622',\n",
       " '+',\n",
       " 'Rituximab',\n",
       " 'TTI-622',\n",
       " '+',\n",
       " 'PD-1/PD-L1',\n",
       " 'Inhibitor',\n",
       " 'TTI-622',\n",
       " '+',\n",
       " 'Proteasome-inhibitor',\n",
       " 'Regimen',\n",
       " 'Radiation',\n",
       " ':',\n",
       " '18F-FHBG',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Aldesleukin',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Cellular',\n",
       " 'Therapy',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Computed',\n",
       " 'Tomography',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Filgrastim',\n",
       " 'Lenalidomide',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Leukapheresis',\n",
       " 'Melphalan',\n",
       " 'Plerixafor',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Positron',\n",
       " 'Emission',\n",
       " 'Tomography',\n",
       " 'AMG',\n",
       " '424',\n",
       " 'Carfilzomib',\n",
       " 'Dexamethasone',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Nivolumab',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Wild-type',\n",
       " 'Reovirus',\n",
       " 'selinexor',\n",
       " 'carfilzomib',\n",
       " 'dexamethasone',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Abatacept',\n",
       " 'Dexamethasone',\n",
       " 'Ixazomib',\n",
       " 'Citrate',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'BCMA-specific',\n",
       " 'CAR-expressing',\n",
       " 'T',\n",
       " 'Lymphocytes',\n",
       " 'Cyclophosphamide',\n",
       " 'Fludarabine',\n",
       " 'Gamma-Secretase',\n",
       " 'Inhibitor',\n",
       " 'LY3039478',\n",
       " 'SEA-BCMA',\n",
       " 'Combination',\n",
       " 'Product',\n",
       " ':',\n",
       " 'BCMA',\n",
       " 'CART',\n",
       " '+',\n",
       " 'huCART19',\n",
       " 'Combination',\n",
       " 'Product',\n",
       " ':',\n",
       " 'CART',\n",
       " 'BCMA',\n",
       " 'or',\n",
       " 'CART',\n",
       " 'BCMA',\n",
       " '+',\n",
       " 'huCART19',\n",
       " 'Combination',\n",
       " 'Product',\n",
       " ':',\n",
       " 'Single-dose',\n",
       " 'infusion',\n",
       " 'of',\n",
       " 'CART',\n",
       " 'BCMA',\n",
       " 'or',\n",
       " 'CART',\n",
       " 'BCMA',\n",
       " '+',\n",
       " 'huCART19',\n",
       " 'Pomalidomide',\n",
       " 'Carfilzomib',\n",
       " 'dexamethasone',\n",
       " 'Daratumumab',\n",
       " 'Phase',\n",
       " '1a',\n",
       " ':',\n",
       " 'CWP232291',\n",
       " 'Phase',\n",
       " '1b',\n",
       " ':',\n",
       " 'CWP232291',\n",
       " ',',\n",
       " 'Lenalidomide',\n",
       " ',',\n",
       " 'Dexamethasone',\n",
       " 'Radiation',\n",
       " ':',\n",
       " 'Total',\n",
       " 'Body',\n",
       " 'Irradiation',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Haploidentical',\n",
       " 'Stem',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'CD56-Enriched',\n",
       " 'Donor',\n",
       " 'Lymphocyte',\n",
       " 'Infusion',\n",
       " 'Bendamustine',\n",
       " 'Fludarabine',\n",
       " 'Rituximab',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Dose',\n",
       " 'Escalation',\n",
       " ',',\n",
       " 'MEDI2228',\n",
       " ',',\n",
       " 'ADC',\n",
       " '(',\n",
       " 'antibody',\n",
       " 'drug',\n",
       " 'conjugate',\n",
       " ')',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Dose',\n",
       " 'Expansion',\n",
       " ',',\n",
       " 'MEDI2228',\n",
       " ',',\n",
       " 'ADC',\n",
       " '(',\n",
       " 'antibody',\n",
       " 'drug',\n",
       " 'conjugate',\n",
       " ')',\n",
       " 'Genetic',\n",
       " ':',\n",
       " 'NY-ESO-1ᶜ²⁵⁹T',\n",
       " 'cells',\n",
       " 'NY-ESO-1ᶜ²⁵⁹T',\n",
       " 'in',\n",
       " 'combination',\n",
       " 'with',\n",
       " 'pembrolizumab',\n",
       " 'Immediate',\n",
       " 'Release',\n",
       " '(',\n",
       " 'IR',\n",
       " ')',\n",
       " 'Formulation',\n",
       " 'Gastro-Retentive',\n",
       " '(',\n",
       " 'GR',\n",
       " ')',\n",
       " 'Formulation',\n",
       " 'Dexamethasone',\n",
       " 'Pomalidomide',\n",
       " 'Clarithromycin',\n",
       " 'Dexamethasone',\n",
       " 'Ixazomib',\n",
       " 'Citrate',\n",
       " 'Pomalidomide',\n",
       " 'PT-112',\n",
       " 'Carfilzomib',\n",
       " 'Venetoclax',\n",
       " 'Dexamethasone',\n",
       " 'Melflufen',\n",
       " 'Dexamethasone',\n",
       " 'Combination',\n",
       " 'Product',\n",
       " ':',\n",
       " 'Dexamethasone',\n",
       " 'Combination',\n",
       " 'Product',\n",
       " ':',\n",
       " 'Carfilzomib',\n",
       " 'Ixazomib',\n",
       " 'Pomalidomide',\n",
       " 'Dexamethasone',\n",
       " 'Elotuzumab',\n",
       " 'Pomalidomide',\n",
       " 'Carfilzomib',\n",
       " 'Dexamethasone',\n",
       " 'POM',\n",
       " 'Steroids',\n",
       " 'PLD',\n",
       " 'CFZ',\n",
       " 'BTZ',\n",
       " 'CLA',\n",
       " 'CY',\n",
       " 'Dexamethasone',\n",
       " 'ABT-199',\n",
       " 'Pomalidomide',\n",
       " 'Dexamethasone',\n",
       " 'Venetoclax',\n",
       " 'Carfilzomib',\n",
       " 'Dexamethasone',\n",
       " 'Prednisone',\n",
       " 'Methylprednisolone',\n",
       " 'Lenalidomide',\n",
       " 'Pomalidomide',\n",
       " 'Elotuzumab',\n",
       " 'Pomalidomide',\n",
       " 'Bortezomib',\n",
       " 'Dexamethasone',\n",
       " 'Dexamethasone',\n",
       " 'Daratumumab',\n",
       " 'Venetoclax',\n",
       " 'Bortezomib',\n",
       " 'CC-93269',\n",
       " 'Genetic',\n",
       " ':',\n",
       " 'Autologous',\n",
       " 'genetically',\n",
       " 'modified',\n",
       " 'anti-BCMA',\n",
       " 'CAR',\n",
       " 'transduced',\n",
       " 'T',\n",
       " 'cells',\n",
       " '(',\n",
       " 'KITE-585',\n",
       " ')',\n",
       " 'Cyclophosphamide',\n",
       " 'Fludarabine',\n",
       " 'PF-06863135',\n",
       " 'CC-92480',\n",
       " 'Dexamethasone',\n",
       " 'Venetoclax',\n",
       " 'Pomalidomide',\n",
       " 'Dexamethasone',\n",
       " 'AMG',\n",
       " '176',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'JCARH125',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'BION-1301',\n",
       " 'Ixazomib',\n",
       " 'Daratumumab',\n",
       " 'Dexamethasone',\n",
       " 'BFCR4350A',\n",
       " 'TAK-079',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Nicotinamide',\n",
       " 'Expanded',\n",
       " 'Haploidentical',\n",
       " 'or',\n",
       " 'Mismatched',\n",
       " 'Related',\n",
       " 'Donor',\n",
       " 'Natural',\n",
       " 'Killer',\n",
       " 'Cells',\n",
       " 'Carfilzomib',\n",
       " 'Pomalidomide',\n",
       " 'Dexamethasone',\n",
       " 'Melflufen',\n",
       " 'Pomalidomide',\n",
       " 'Dexamethasone',\n",
       " 'Ruxolitinib',\n",
       " 'Oral',\n",
       " 'Tablet',\n",
       " '[',\n",
       " 'Jakafi',\n",
       " ']',\n",
       " 'Lenalidomide',\n",
       " '5Mg',\n",
       " 'Oral',\n",
       " 'Capsule',\n",
       " 'Methyl',\n",
       " 'Prednisolonate',\n",
       " 'Isatuximab',\n",
       " 'SAR650984',\n",
       " 'Cemiplimab',\n",
       " 'REGN2810',\n",
       " 'Elotuzumab',\n",
       " 'Pomalidomide',\n",
       " 'Dexamethasone',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Autologous',\n",
       " 'stem',\n",
       " 'cell',\n",
       " 'transplant',\n",
       " 'Melphalan',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Pembrolizumab',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Daratumumab',\n",
       " 'Selinexor',\n",
       " 'Ixazomib',\n",
       " 'Dexamethasone',\n",
       " 'panobinostat',\n",
       " 'capsules',\n",
       " 'bortezomib',\n",
       " 'injection',\n",
       " 'dexamethasone',\n",
       " 'tablets',\n",
       " 'CC-220',\n",
       " 'Dexamethasone',\n",
       " 'Daratumumab',\n",
       " 'Bortezomib',\n",
       " '(',\n",
       " 'BTZ',\n",
       " ')',\n",
       " 'Selinexor',\n",
       " 'Dexamethasone',\n",
       " 'Lenalidomide',\n",
       " 'Pomalidomide',\n",
       " 'Bortezomib',\n",
       " 'Daratumumab',\n",
       " 'Carfilzomib',\n",
       " 'Melphalan',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'JNJ-68284528',\n",
       " 'Dara',\n",
       " 'SC',\n",
       " 'Dara',\n",
       " 'IV',\n",
       " 'Carfilzomib',\n",
       " 'Lenalidomide',\n",
       " 'Dexamethasone',\n",
       " 'Daratumumab',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'autologous',\n",
       " 'hematopoietic',\n",
       " 'cell',\n",
       " 'transplantation',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'P-BCMA-101',\n",
       " 'CAR-T',\n",
       " 'cells',\n",
       " 'Rimiducid',\n",
       " 'Daratumumab',\n",
       " 'Subcutaneous',\n",
       " '(',\n",
       " 'SC',\n",
       " ')',\n",
       " 'Administration',\n",
       " 'Recombinant',\n",
       " 'Human',\n",
       " 'Hyaluronidase',\n",
       " '[',\n",
       " 'rHuPH20',\n",
       " ']',\n",
       " ')',\n",
       " 'SC',\n",
       " 'Administration',\n",
       " 'MIK665',\n",
       " 'AMG',\n",
       " '701',\n",
       " 'isatuximab',\n",
       " 'SAR650984',\n",
       " 'carfilzomib',\n",
       " 'dexamethasone',\n",
       " 'GSK2857916',\n",
       " 'frozen',\n",
       " 'GSK2857916',\n",
       " 'lyophilized',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'bb21217',\n",
       " 'Melphalan',\n",
       " 'Hydrochloride',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Kappa',\n",
       " 'CD28',\n",
       " 'T',\n",
       " 'cells',\n",
       " 'Dexamethasone',\n",
       " 'Ixazomib',\n",
       " 'Lenalidomide',\n",
       " 'Pralatrexate',\n",
       " 'Romidepsin',\n",
       " 'Abemaciclib',\n",
       " ',',\n",
       " 'dexamethasone',\n",
       " ',',\n",
       " 'ixazomib',\n",
       " ',',\n",
       " 'pomalidomide',\n",
       " 'Enasidenib',\n",
       " ',',\n",
       " 'dexamethasone',\n",
       " ',',\n",
       " 'ixazomib',\n",
       " ',',\n",
       " 'pomalidomide',\n",
       " 'Cobimetinib',\n",
       " ',',\n",
       " 'dexamethasone',\n",
       " ',',\n",
       " 'ixazomib',\n",
       " ',',\n",
       " 'pomalidomide',\n",
       " 'Erdafitinib',\n",
       " ',',\n",
       " 'dexamethasone',\n",
       " ',',\n",
       " 'ixazomib',\n",
       " ',',\n",
       " 'pomalidomide',\n",
       " 'Venetoclax',\n",
       " ',',\n",
       " 'dexamethasone',\n",
       " ',',\n",
       " 'ixazomib',\n",
       " ',',\n",
       " 'pomalidomide',\n",
       " 'Daratumumab',\n",
       " ',',\n",
       " 'dexamethasone',\n",
       " ',',\n",
       " 'ixazomib',\n",
       " ',',\n",
       " 'pomalidomide',\n",
       " 'Ixazomib',\n",
       " 'Citrate',\n",
       " 'Lenalidomide',\n",
       " 'Isatuximab',\n",
       " 'JNJ-64007957',\n",
       " 'JNJ-64407564',\n",
       " 'PDR001',\n",
       " 'CJM112',\n",
       " 'LCL161',\n",
       " 'Selinexor',\n",
       " 'Bortezomib',\n",
       " 'Dexamethasone',\n",
       " 'Melflufen',\n",
       " 'Dexamethasone',\n",
       " 'Bortezomib',\n",
       " 'Daratumumab',\n",
       " 'SGN-CD48A',\n",
       " 'Isatuximab',\n",
       " 'SAR650984',\n",
       " 'Pomalidomide',\n",
       " 'Dexamethasone',\n",
       " 'Treatment',\n",
       " 'with',\n",
       " 'TINOSTAMUSTINE',\n",
       " 'Atezolizumab',\n",
       " '(',\n",
       " 'MPDL3280A',\n",
       " ')',\n",
       " ',',\n",
       " 'an',\n",
       " 'engineered',\n",
       " 'anti-PD-L1',\n",
       " 'antibody',\n",
       " 'Daratumumab',\n",
       " 'Lenalidomide',\n",
       " 'Pomalidomide',\n",
       " 'Dexamethasone',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Nivolumab',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Ipilimumab',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Lirilumab',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Daratumumab',\n",
       " 'Pomalidomide',\n",
       " 'Dexamethasone',\n",
       " 'MEDI7247',\n",
       " 'NK',\n",
       " 'cells',\n",
       " '+CliniMACs',\n",
       " 'CD3',\n",
       " 'and',\n",
       " 'CD56',\n",
       " 'systems',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'NK',\n",
       " 'cells',\n",
       " 'KPT-8602',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Allogeneic',\n",
       " 'Bone',\n",
       " 'Marrow',\n",
       " 'Transplantation',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Allogeneic',\n",
       " 'Hematopoietic',\n",
       " 'Stem',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Autologous',\n",
       " 'Hematopoietic',\n",
       " 'Stem',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Autologous-Allogeneic',\n",
       " 'Tandem',\n",
       " 'Hematopoietic',\n",
       " 'Stem',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Carmustine',\n",
       " 'Cyclophosphamide',\n",
       " 'Cytarabine',\n",
       " 'Etoposide',\n",
       " 'Fludarabine',\n",
       " 'Phosphate',\n",
       " 'Melphalan',\n",
       " 'Mycophenolate',\n",
       " 'Mofetil',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Peripheral',\n",
       " 'Blood',\n",
       " 'Stem',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Tacrolimus',\n",
       " 'Radiation',\n",
       " ':',\n",
       " 'Total-Body',\n",
       " 'Irradiation',\n",
       " 'busulfan',\n",
       " 'cyclophosphamide',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Stem',\n",
       " 'cell',\n",
       " 'infusion',\n",
       " 'Radiation',\n",
       " ':',\n",
       " 'Total',\n",
       " 'body',\n",
       " 'irradiation',\n",
       " 'Adavosertib',\n",
       " 'Afatinib',\n",
       " 'Binimetinib',\n",
       " 'Capivasertib',\n",
       " 'Crizotinib',\n",
       " 'Dabrafenib',\n",
       " 'Dasatinib',\n",
       " 'Defactinib',\n",
       " 'FGFR',\n",
       " 'Inhibitor',\n",
       " 'AZD4547',\n",
       " 'Larotrectinib',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Nivolumab',\n",
       " 'Osimertinib',\n",
       " 'Palbociclib',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Pertuzumab',\n",
       " 'PI3K-beta',\n",
       " 'Inhibitor',\n",
       " 'GSK2636771',\n",
       " 'Sapanisertib',\n",
       " 'Sunitinib',\n",
       " 'Malate',\n",
       " 'Taselisib',\n",
       " 'Trametinib',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Trastuzumab',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Trastuzumab',\n",
       " 'Emtansine',\n",
       " 'Vismodegib',\n",
       " 'AMG',\n",
       " '397',\n",
       " 'RO6870810',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'daratumumab',\n",
       " 'EDO-S101',\n",
       " 'Nivolumab',\n",
       " 'Tocilizumab',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'NKR-2',\n",
       " 'cells',\n",
       " 'AZD5991',\n",
       " 'Dasatinib',\n",
       " 'CLR',\n",
       " '131',\n",
       " 'Fludarabine',\n",
       " 'Radiation',\n",
       " ':',\n",
       " 'Total-Body',\n",
       " 'Irradiation',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'T',\n",
       " 'Cell-Depleted',\n",
       " 'Donor',\n",
       " 'Lymphocyte',\n",
       " 'Infusion',\n",
       " 'Cyclophosphamide',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Peripheral',\n",
       " 'Blood',\n",
       " 'Stem',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Allogeneic',\n",
       " 'Hematopoietic',\n",
       " 'Stem',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Tacrolimus',\n",
       " 'Mycophenolate',\n",
       " 'mofetil',\n",
       " 'Fludarabine',\n",
       " 'phosphate',\n",
       " 'Thiotepa',\n",
       " 'Radiation',\n",
       " ':',\n",
       " 'Total',\n",
       " 'body',\n",
       " 'irradiation',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Therapeutic',\n",
       " 'allogeneic',\n",
       " 'lymphocytes',\n",
       " 'Cyclophosphamide',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Allogeneic',\n",
       " 'hematopoietic',\n",
       " 'stem',\n",
       " 'cell',\n",
       " 'transplantation',\n",
       " '(',\n",
       " 'HSCT',\n",
       " ')',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Peripheral',\n",
       " 'blood',\n",
       " 'stem',\n",
       " 'cell',\n",
       " 'transplantation',\n",
       " 'Tacrolimus',\n",
       " 'Mycophenolate',\n",
       " 'mofetil',\n",
       " 'Fludarabine',\n",
       " 'Busulfan',\n",
       " 'Radiation',\n",
       " ':',\n",
       " 'Total',\n",
       " 'Body',\n",
       " 'Irradiation',\n",
       " '(',\n",
       " 'TBI',\n",
       " ')',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Donor',\n",
       " 'Lymphocyte',\n",
       " 'Infusion',\n",
       " '(',\n",
       " 'DLI',\n",
       " ')',\n",
       " 'Cyclophosphamide',\n",
       " '(',\n",
       " 'CY',\n",
       " ')',\n",
       " 'Tacrolimus',\n",
       " 'Mycophenolate',\n",
       " 'mofetil',\n",
       " 'Device',\n",
       " ':',\n",
       " 'Allogeneic',\n",
       " 'hematopoietic',\n",
       " 'stem',\n",
       " 'cell',\n",
       " 'transplantation',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Peripheral',\n",
       " 'blood',\n",
       " 'stem',\n",
       " 'cell',\n",
       " 'transplantation',\n",
       " '(',\n",
       " 'PBSCT',\n",
       " ')',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'HSCT',\n",
       " 'with',\n",
       " 'TBI',\n",
       " 'Regimen',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'HSCT',\n",
       " 'with',\n",
       " 'Non-TBI',\n",
       " 'Regimen',\n",
       " 'Device',\n",
       " ':',\n",
       " \"3'-deoxy-3'-\",\n",
       " '[',\n",
       " '18F',\n",
       " ']',\n",
       " 'fluorothymidine',\n",
       " 'rhIL-2',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'PNK-007',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Allogeneic',\n",
       " 'Hematopoietic',\n",
       " 'Stem',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Irradiated',\n",
       " 'Allogeneic',\n",
       " 'Cells',\n",
       " 'Cyclophosphamide',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Filgrastim',\n",
       " 'Fludarabine',\n",
       " 'Phosphate',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Laboratory',\n",
       " 'Biomarker',\n",
       " 'Analysis',\n",
       " 'Mycophenolate',\n",
       " 'Mofetil',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Nonmyeloablative',\n",
       " 'Allogeneic',\n",
       " 'Hematopoietic',\n",
       " 'Stem',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Peripheral',\n",
       " 'Blood',\n",
       " 'Stem',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Tacrolimus',\n",
       " 'Radiation',\n",
       " ':',\n",
       " 'Total-Body',\n",
       " 'Irradiation',\n",
       " 'Busulfan',\n",
       " 'Cyclophosphamide',\n",
       " 'Fludarabine',\n",
       " 'Phosphate',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Hematopoietic',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Melphalan',\n",
       " 'Hydrochloride',\n",
       " 'Mycophenolate',\n",
       " 'Mofetil',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Peripheral',\n",
       " 'Blood',\n",
       " 'Stem',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Tacrolimus',\n",
       " ...]"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "word_lst"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [],
   "source": [
    "fdist1 = nltk.FreqDist(word_lst)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "fdist1.plot()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['DS-3032b',\n",
       " 'ONC201',\n",
       " 'Ixazomib',\n",
       " 'Dexamethasone',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'bb2121',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'CAR2',\n",
       " 'Anti-CD38',\n",
       " 'A2',\n",
       " 'CAR-T',\n",
       " 'Cells',\n",
       " 'Ixazomib',\n",
       " 'Pomalidomide',\n",
       " 'Dexamethasone',\n",
       " 'Daratumumab',\n",
       " 'SAR650984',\n",
       " 'Carfilzomib',\n",
       " 'Cabozantinib',\n",
       " 'bb2121',\n",
       " 'Daratumumab',\n",
       " 'Pomalidomide',\n",
       " 'Dexamethasone',\n",
       " 'Bortezomib',\n",
       " 'Ixazomib',\n",
       " 'Lenalidomide',\n",
       " 'Lenalidomide',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Nivolumab',\n",
       " 'Bortezomib',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Daratumumab',\n",
       " 'Dexamethasone',\n",
       " 'Ixazomib',\n",
       " 'Carfilzomib',\n",
       " 'Dexamethasone',\n",
       " 'Panobinostat',\n",
       " 'ABC294640',\n",
       " 'Dexamethasone',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Elotuzumab',\n",
       " 'Pomalidomide',\n",
       " 'ONC201',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Autologous',\n",
       " 'Hematopoietic',\n",
       " 'Stem',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Dexamethasone',\n",
       " 'Ixazomib',\n",
       " 'Citrate',\n",
       " 'Pomalidomide',\n",
       " 'GSK2857916',\n",
       " 'Lenalidomide',\n",
       " 'Dexamethasone',\n",
       " 'Bortezomib',\n",
       " 'RP2D',\n",
       " 'of',\n",
       " 'GSK2857916',\n",
       " 'Lintuzumab',\n",
       " 'AC',\n",
       " '225',\n",
       " 'ABI-009',\n",
       " 'Pomalidomide',\n",
       " 'Dexamethasone',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Biospecimen',\n",
       " 'Collection',\n",
       " 'Device',\n",
       " ':',\n",
       " 'High',\n",
       " 'Throughput',\n",
       " 'Screening',\n",
       " 'CAR138',\n",
       " 'T',\n",
       " 'Cells',\n",
       " 'Elotuzumab',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Autologous',\n",
       " 'Hematopoietic',\n",
       " 'Stem',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Busulfan',\n",
       " 'Gemcitabine',\n",
       " 'Hydrochloride',\n",
       " 'Melphalan',\n",
       " 'Panobinostat',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Peripheral',\n",
       " 'Blood',\n",
       " 'Stem',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Guided',\n",
       " 'Lesion',\n",
       " 'Biopsies',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Standard',\n",
       " 'Lesion',\n",
       " 'Biopsies',\n",
       " 'Dabrafenib',\n",
       " 'Trametinib',\n",
       " 'Carfilzomib',\n",
       " 'Ruxolitinib',\n",
       " 'Dexamethasone',\n",
       " 'Blinatumomab',\n",
       " 'MV-NIS',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'CS1-CAR',\n",
       " 'T',\n",
       " 'Therapy',\n",
       " 'Cyclophosphamide',\n",
       " 'Fludarabine',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Leukapheresis',\n",
       " 'Cyclophosphamide',\n",
       " 'Dexamethasone',\n",
       " 'Ixazomib',\n",
       " 'Citrate',\n",
       " 'TEW-7197',\n",
       " 'Pomalidomide',\n",
       " 'SL-401/',\n",
       " 'Pomalidomide/',\n",
       " 'Dexamethasone',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Pembrolizumab',\n",
       " 'Radiation',\n",
       " ':',\n",
       " 'Radiation',\n",
       " 'Therapy',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Autologous',\n",
       " 'Anti-BCMA-CAR-expressing',\n",
       " 'CD4+/CD8+',\n",
       " 'T-lymphocytes',\n",
       " 'FCARH143',\n",
       " 'Cyclophosphamide',\n",
       " 'Fludarabine',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Leukapheresis',\n",
       " 'I-131-CLR1404',\n",
       " 'dexamethasone',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'ACTR087',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'SEA-BCMA',\n",
       " 'ACE-011',\n",
       " 'Lenalidomide',\n",
       " 'Dexamethasone',\n",
       " 'Pomalidomide',\n",
       " 'TAK-573',\n",
       " 'TTI-622',\n",
       " 'Monotherapy',\n",
       " 'TTI-622',\n",
       " '+',\n",
       " 'Rituximab',\n",
       " 'TTI-622',\n",
       " '+',\n",
       " 'PD-1/PD-L1',\n",
       " 'Inhibitor',\n",
       " 'TTI-622',\n",
       " '+',\n",
       " 'Proteasome-inhibitor',\n",
       " 'Regimen',\n",
       " 'Radiation',\n",
       " ':',\n",
       " '18F-FHBG',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Aldesleukin',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Cellular',\n",
       " 'Therapy',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Computed',\n",
       " 'Tomography',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Filgrastim',\n",
       " 'Lenalidomide',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Leukapheresis',\n",
       " 'Melphalan',\n",
       " 'Plerixafor',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Positron',\n",
       " 'Emission',\n",
       " 'Tomography',\n",
       " 'AMG',\n",
       " '424',\n",
       " 'Carfilzomib',\n",
       " 'Dexamethasone',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Nivolumab',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Wild-type',\n",
       " 'Reovirus',\n",
       " 'selinexor',\n",
       " 'carfilzomib',\n",
       " 'dexamethasone',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Abatacept',\n",
       " 'Dexamethasone',\n",
       " 'Ixazomib',\n",
       " 'Citrate',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'BCMA-specific',\n",
       " 'CAR-expressing',\n",
       " 'T',\n",
       " 'Lymphocytes',\n",
       " 'Cyclophosphamide',\n",
       " 'Fludarabine',\n",
       " 'Gamma-Secretase',\n",
       " 'Inhibitor',\n",
       " 'LY3039478',\n",
       " 'SEA-BCMA',\n",
       " 'Combination',\n",
       " 'Product',\n",
       " ':',\n",
       " 'BCMA',\n",
       " 'CART',\n",
       " '+',\n",
       " 'huCART19',\n",
       " 'Combination',\n",
       " 'Product',\n",
       " ':',\n",
       " 'CART',\n",
       " 'BCMA',\n",
       " 'or',\n",
       " 'CART',\n",
       " 'BCMA',\n",
       " '+',\n",
       " 'huCART19',\n",
       " 'Combination',\n",
       " 'Product',\n",
       " ':',\n",
       " 'Single-dose',\n",
       " 'infusion',\n",
       " 'of',\n",
       " 'CART',\n",
       " 'BCMA',\n",
       " 'or',\n",
       " 'CART',\n",
       " 'BCMA',\n",
       " '+',\n",
       " 'huCART19',\n",
       " 'Pomalidomide',\n",
       " 'Carfilzomib',\n",
       " 'dexamethasone',\n",
       " 'Daratumumab',\n",
       " 'Phase',\n",
       " '1a',\n",
       " ':',\n",
       " 'CWP232291',\n",
       " 'Phase',\n",
       " '1b',\n",
       " ':',\n",
       " 'CWP232291',\n",
       " ',',\n",
       " 'Lenalidomide',\n",
       " ',',\n",
       " 'Dexamethasone',\n",
       " 'Radiation',\n",
       " ':',\n",
       " 'Total',\n",
       " 'Body',\n",
       " 'Irradiation',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Haploidentical',\n",
       " 'Stem',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'CD56-Enriched',\n",
       " 'Donor',\n",
       " 'Lymphocyte',\n",
       " 'Infusion',\n",
       " 'Bendamustine',\n",
       " 'Fludarabine',\n",
       " 'Rituximab',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Dose',\n",
       " 'Escalation',\n",
       " ',',\n",
       " 'MEDI2228',\n",
       " ',',\n",
       " 'ADC',\n",
       " '(',\n",
       " 'antibody',\n",
       " 'drug',\n",
       " 'conjugate',\n",
       " ')',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Dose',\n",
       " 'Expansion',\n",
       " ',',\n",
       " 'MEDI2228',\n",
       " ',',\n",
       " 'ADC',\n",
       " '(',\n",
       " 'antibody',\n",
       " 'drug',\n",
       " 'conjugate',\n",
       " ')',\n",
       " 'Genetic',\n",
       " ':',\n",
       " 'NY-ESO-1ᶜ²⁵⁹T',\n",
       " 'cells',\n",
       " 'NY-ESO-1ᶜ²⁵⁹T',\n",
       " 'in',\n",
       " 'combination',\n",
       " 'with',\n",
       " 'pembrolizumab',\n",
       " 'Immediate',\n",
       " 'Release',\n",
       " '(',\n",
       " 'IR',\n",
       " ')',\n",
       " 'Formulation',\n",
       " 'Gastro-Retentive',\n",
       " '(',\n",
       " 'GR',\n",
       " ')',\n",
       " 'Formulation',\n",
       " 'Dexamethasone',\n",
       " 'Pomalidomide',\n",
       " 'Clarithromycin',\n",
       " 'Dexamethasone',\n",
       " 'Ixazomib',\n",
       " 'Citrate',\n",
       " 'Pomalidomide',\n",
       " 'PT-112',\n",
       " 'Carfilzomib',\n",
       " 'Venetoclax',\n",
       " 'Dexamethasone',\n",
       " 'Melflufen',\n",
       " 'Dexamethasone',\n",
       " 'Combination',\n",
       " 'Product',\n",
       " ':',\n",
       " 'Dexamethasone',\n",
       " 'Combination',\n",
       " 'Product',\n",
       " ':',\n",
       " 'Carfilzomib',\n",
       " 'Ixazomib',\n",
       " 'Pomalidomide',\n",
       " 'Dexamethasone',\n",
       " 'Elotuzumab',\n",
       " 'Pomalidomide',\n",
       " 'Carfilzomib',\n",
       " 'Dexamethasone',\n",
       " 'POM',\n",
       " 'Steroids',\n",
       " 'PLD',\n",
       " 'CFZ',\n",
       " 'BTZ',\n",
       " 'CLA',\n",
       " 'CY',\n",
       " 'Dexamethasone',\n",
       " 'ABT-199',\n",
       " 'Pomalidomide',\n",
       " 'Dexamethasone',\n",
       " 'Venetoclax',\n",
       " 'Carfilzomib',\n",
       " 'Dexamethasone',\n",
       " 'Prednisone',\n",
       " 'Methylprednisolone',\n",
       " 'Lenalidomide',\n",
       " 'Pomalidomide',\n",
       " 'Elotuzumab',\n",
       " 'Pomalidomide',\n",
       " 'Bortezomib',\n",
       " 'Dexamethasone',\n",
       " 'Dexamethasone',\n",
       " 'Daratumumab',\n",
       " 'Venetoclax',\n",
       " 'Bortezomib',\n",
       " 'CC-93269',\n",
       " 'Genetic',\n",
       " ':',\n",
       " 'Autologous',\n",
       " 'genetically',\n",
       " 'modified',\n",
       " 'anti-BCMA',\n",
       " 'CAR',\n",
       " 'transduced',\n",
       " 'T',\n",
       " 'cells',\n",
       " '(',\n",
       " 'KITE-585',\n",
       " ')',\n",
       " 'Cyclophosphamide',\n",
       " 'Fludarabine',\n",
       " 'PF-06863135',\n",
       " 'CC-92480',\n",
       " 'Dexamethasone',\n",
       " 'Venetoclax',\n",
       " 'Pomalidomide',\n",
       " 'Dexamethasone',\n",
       " 'AMG',\n",
       " '176',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'JCARH125',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'BION-1301',\n",
       " 'Ixazomib',\n",
       " 'Daratumumab',\n",
       " 'Dexamethasone',\n",
       " 'BFCR4350A',\n",
       " 'TAK-079',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Nicotinamide',\n",
       " 'Expanded',\n",
       " 'Haploidentical',\n",
       " 'or',\n",
       " 'Mismatched',\n",
       " 'Related',\n",
       " 'Donor',\n",
       " 'Natural',\n",
       " 'Killer',\n",
       " 'Cells',\n",
       " 'Carfilzomib',\n",
       " 'Pomalidomide',\n",
       " 'Dexamethasone',\n",
       " 'Melflufen',\n",
       " 'Pomalidomide',\n",
       " 'Dexamethasone',\n",
       " 'Ruxolitinib',\n",
       " 'Oral',\n",
       " 'Tablet',\n",
       " '[',\n",
       " 'Jakafi',\n",
       " ']',\n",
       " 'Lenalidomide',\n",
       " '5Mg',\n",
       " 'Oral',\n",
       " 'Capsule',\n",
       " 'Methyl',\n",
       " 'Prednisolonate',\n",
       " 'Isatuximab',\n",
       " 'SAR650984',\n",
       " 'Cemiplimab',\n",
       " 'REGN2810',\n",
       " 'Elotuzumab',\n",
       " 'Pomalidomide',\n",
       " 'Dexamethasone',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Autologous',\n",
       " 'stem',\n",
       " 'cell',\n",
       " 'transplant',\n",
       " 'Melphalan',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Pembrolizumab',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Daratumumab',\n",
       " 'Selinexor',\n",
       " 'Ixazomib',\n",
       " 'Dexamethasone',\n",
       " 'panobinostat',\n",
       " 'capsules',\n",
       " 'bortezomib',\n",
       " 'injection',\n",
       " 'dexamethasone',\n",
       " 'tablets',\n",
       " 'CC-220',\n",
       " 'Dexamethasone',\n",
       " 'Daratumumab',\n",
       " 'Bortezomib',\n",
       " '(',\n",
       " 'BTZ',\n",
       " ')',\n",
       " 'Selinexor',\n",
       " 'Dexamethasone',\n",
       " 'Lenalidomide',\n",
       " 'Pomalidomide',\n",
       " 'Bortezomib',\n",
       " 'Daratumumab',\n",
       " 'Carfilzomib',\n",
       " 'Melphalan',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'JNJ-68284528',\n",
       " 'Dara',\n",
       " 'SC',\n",
       " 'Dara',\n",
       " 'IV',\n",
       " 'Carfilzomib',\n",
       " 'Lenalidomide',\n",
       " 'Dexamethasone',\n",
       " 'Daratumumab',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'autologous',\n",
       " 'hematopoietic',\n",
       " 'cell',\n",
       " 'transplantation',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'P-BCMA-101',\n",
       " 'CAR-T',\n",
       " 'cells',\n",
       " 'Rimiducid',\n",
       " 'Daratumumab',\n",
       " 'Subcutaneous',\n",
       " '(',\n",
       " 'SC',\n",
       " ')',\n",
       " 'Administration',\n",
       " 'Recombinant',\n",
       " 'Human',\n",
       " 'Hyaluronidase',\n",
       " '[',\n",
       " 'rHuPH20',\n",
       " ']',\n",
       " ')',\n",
       " 'SC',\n",
       " 'Administration',\n",
       " 'MIK665',\n",
       " 'AMG',\n",
       " '701',\n",
       " 'isatuximab',\n",
       " 'SAR650984',\n",
       " 'carfilzomib',\n",
       " 'dexamethasone',\n",
       " 'GSK2857916',\n",
       " 'frozen',\n",
       " 'GSK2857916',\n",
       " 'lyophilized',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'bb21217',\n",
       " 'Melphalan',\n",
       " 'Hydrochloride',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Kappa',\n",
       " 'CD28',\n",
       " 'T',\n",
       " 'cells',\n",
       " 'Dexamethasone',\n",
       " 'Ixazomib',\n",
       " 'Lenalidomide',\n",
       " 'Pralatrexate',\n",
       " 'Romidepsin',\n",
       " 'Abemaciclib',\n",
       " ',',\n",
       " 'dexamethasone',\n",
       " ',',\n",
       " 'ixazomib',\n",
       " ',',\n",
       " 'pomalidomide',\n",
       " 'Enasidenib',\n",
       " ',',\n",
       " 'dexamethasone',\n",
       " ',',\n",
       " 'ixazomib',\n",
       " ',',\n",
       " 'pomalidomide',\n",
       " 'Cobimetinib',\n",
       " ',',\n",
       " 'dexamethasone',\n",
       " ',',\n",
       " 'ixazomib',\n",
       " ',',\n",
       " 'pomalidomide',\n",
       " 'Erdafitinib',\n",
       " ',',\n",
       " 'dexamethasone',\n",
       " ',',\n",
       " 'ixazomib',\n",
       " ',',\n",
       " 'pomalidomide',\n",
       " 'Venetoclax',\n",
       " ',',\n",
       " 'dexamethasone',\n",
       " ',',\n",
       " 'ixazomib',\n",
       " ',',\n",
       " 'pomalidomide',\n",
       " 'Daratumumab',\n",
       " ',',\n",
       " 'dexamethasone',\n",
       " ',',\n",
       " 'ixazomib',\n",
       " ',',\n",
       " 'pomalidomide',\n",
       " 'Ixazomib',\n",
       " 'Citrate',\n",
       " 'Lenalidomide',\n",
       " 'Isatuximab',\n",
       " 'JNJ-64007957',\n",
       " 'JNJ-64407564',\n",
       " 'PDR001',\n",
       " 'CJM112',\n",
       " 'LCL161',\n",
       " 'Selinexor',\n",
       " 'Bortezomib',\n",
       " 'Dexamethasone',\n",
       " 'Melflufen',\n",
       " 'Dexamethasone',\n",
       " 'Bortezomib',\n",
       " 'Daratumumab',\n",
       " 'SGN-CD48A',\n",
       " 'Isatuximab',\n",
       " 'SAR650984',\n",
       " 'Pomalidomide',\n",
       " 'Dexamethasone',\n",
       " 'Treatment',\n",
       " 'with',\n",
       " 'TINOSTAMUSTINE',\n",
       " 'Atezolizumab',\n",
       " '(',\n",
       " 'MPDL3280A',\n",
       " ')',\n",
       " ',',\n",
       " 'an',\n",
       " 'engineered',\n",
       " 'anti-PD-L1',\n",
       " 'antibody',\n",
       " 'Daratumumab',\n",
       " 'Lenalidomide',\n",
       " 'Pomalidomide',\n",
       " 'Dexamethasone',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Nivolumab',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Ipilimumab',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Lirilumab',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Daratumumab',\n",
       " 'Pomalidomide',\n",
       " 'Dexamethasone',\n",
       " 'MEDI7247',\n",
       " 'NK',\n",
       " 'cells',\n",
       " '+CliniMACs',\n",
       " 'CD3',\n",
       " 'and',\n",
       " 'CD56',\n",
       " 'systems',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'NK',\n",
       " 'cells',\n",
       " 'KPT-8602',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Allogeneic',\n",
       " 'Bone',\n",
       " 'Marrow',\n",
       " 'Transplantation',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Allogeneic',\n",
       " 'Hematopoietic',\n",
       " 'Stem',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Autologous',\n",
       " 'Hematopoietic',\n",
       " 'Stem',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Autologous-Allogeneic',\n",
       " 'Tandem',\n",
       " 'Hematopoietic',\n",
       " 'Stem',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Carmustine',\n",
       " 'Cyclophosphamide',\n",
       " 'Cytarabine',\n",
       " 'Etoposide',\n",
       " 'Fludarabine',\n",
       " 'Phosphate',\n",
       " 'Melphalan',\n",
       " 'Mycophenolate',\n",
       " 'Mofetil',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Peripheral',\n",
       " 'Blood',\n",
       " 'Stem',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Tacrolimus',\n",
       " 'Radiation',\n",
       " ':',\n",
       " 'Total-Body',\n",
       " 'Irradiation',\n",
       " 'busulfan',\n",
       " 'cyclophosphamide',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Stem',\n",
       " 'cell',\n",
       " 'infusion',\n",
       " 'Radiation',\n",
       " ':',\n",
       " 'Total',\n",
       " 'body',\n",
       " 'irradiation',\n",
       " 'Adavosertib',\n",
       " 'Afatinib',\n",
       " 'Binimetinib',\n",
       " 'Capivasertib',\n",
       " 'Crizotinib',\n",
       " 'Dabrafenib',\n",
       " 'Dasatinib',\n",
       " 'Defactinib',\n",
       " 'FGFR',\n",
       " 'Inhibitor',\n",
       " 'AZD4547',\n",
       " 'Larotrectinib',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Nivolumab',\n",
       " 'Osimertinib',\n",
       " 'Palbociclib',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Pertuzumab',\n",
       " 'PI3K-beta',\n",
       " 'Inhibitor',\n",
       " 'GSK2636771',\n",
       " 'Sapanisertib',\n",
       " 'Sunitinib',\n",
       " 'Malate',\n",
       " 'Taselisib',\n",
       " 'Trametinib',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Trastuzumab',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Trastuzumab',\n",
       " 'Emtansine',\n",
       " 'Vismodegib',\n",
       " 'AMG',\n",
       " '397',\n",
       " 'RO6870810',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'daratumumab',\n",
       " 'EDO-S101',\n",
       " 'Nivolumab',\n",
       " 'Tocilizumab',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'NKR-2',\n",
       " 'cells',\n",
       " 'AZD5991',\n",
       " 'Dasatinib',\n",
       " 'CLR',\n",
       " '131',\n",
       " 'Fludarabine',\n",
       " 'Radiation',\n",
       " ':',\n",
       " 'Total-Body',\n",
       " 'Irradiation',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'T',\n",
       " 'Cell-Depleted',\n",
       " 'Donor',\n",
       " 'Lymphocyte',\n",
       " 'Infusion',\n",
       " 'Cyclophosphamide',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Peripheral',\n",
       " 'Blood',\n",
       " 'Stem',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Allogeneic',\n",
       " 'Hematopoietic',\n",
       " 'Stem',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Tacrolimus',\n",
       " 'Mycophenolate',\n",
       " 'mofetil',\n",
       " 'Fludarabine',\n",
       " 'phosphate',\n",
       " 'Thiotepa',\n",
       " 'Radiation',\n",
       " ':',\n",
       " 'Total',\n",
       " 'body',\n",
       " 'irradiation',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Therapeutic',\n",
       " 'allogeneic',\n",
       " 'lymphocytes',\n",
       " 'Cyclophosphamide',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Allogeneic',\n",
       " 'hematopoietic',\n",
       " 'stem',\n",
       " 'cell',\n",
       " 'transplantation',\n",
       " '(',\n",
       " 'HSCT',\n",
       " ')',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Peripheral',\n",
       " 'blood',\n",
       " 'stem',\n",
       " 'cell',\n",
       " 'transplantation',\n",
       " 'Tacrolimus',\n",
       " 'Mycophenolate',\n",
       " 'mofetil',\n",
       " 'Fludarabine',\n",
       " 'Busulfan',\n",
       " 'Radiation',\n",
       " ':',\n",
       " 'Total',\n",
       " 'Body',\n",
       " 'Irradiation',\n",
       " '(',\n",
       " 'TBI',\n",
       " ')',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Donor',\n",
       " 'Lymphocyte',\n",
       " 'Infusion',\n",
       " '(',\n",
       " 'DLI',\n",
       " ')',\n",
       " 'Cyclophosphamide',\n",
       " '(',\n",
       " 'CY',\n",
       " ')',\n",
       " 'Tacrolimus',\n",
       " 'Mycophenolate',\n",
       " 'mofetil',\n",
       " 'Device',\n",
       " ':',\n",
       " 'Allogeneic',\n",
       " 'hematopoietic',\n",
       " 'stem',\n",
       " 'cell',\n",
       " 'transplantation',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Peripheral',\n",
       " 'blood',\n",
       " 'stem',\n",
       " 'cell',\n",
       " 'transplantation',\n",
       " '(',\n",
       " 'PBSCT',\n",
       " ')',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'HSCT',\n",
       " 'with',\n",
       " 'TBI',\n",
       " 'Regimen',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'HSCT',\n",
       " 'with',\n",
       " 'Non-TBI',\n",
       " 'Regimen',\n",
       " 'Device',\n",
       " ':',\n",
       " \"3'-deoxy-3'-\",\n",
       " '[',\n",
       " '18F',\n",
       " ']',\n",
       " 'fluorothymidine',\n",
       " 'rhIL-2',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'PNK-007',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Allogeneic',\n",
       " 'Hematopoietic',\n",
       " 'Stem',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Irradiated',\n",
       " 'Allogeneic',\n",
       " 'Cells',\n",
       " 'Cyclophosphamide',\n",
       " 'Biological',\n",
       " ':',\n",
       " 'Filgrastim',\n",
       " 'Fludarabine',\n",
       " 'Phosphate',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Laboratory',\n",
       " 'Biomarker',\n",
       " 'Analysis',\n",
       " 'Mycophenolate',\n",
       " 'Mofetil',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Nonmyeloablative',\n",
       " 'Allogeneic',\n",
       " 'Hematopoietic',\n",
       " 'Stem',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Peripheral',\n",
       " 'Blood',\n",
       " 'Stem',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Tacrolimus',\n",
       " 'Radiation',\n",
       " ':',\n",
       " 'Total-Body',\n",
       " 'Irradiation',\n",
       " 'Busulfan',\n",
       " 'Cyclophosphamide',\n",
       " 'Fludarabine',\n",
       " 'Phosphate',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Hematopoietic',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Melphalan',\n",
       " 'Hydrochloride',\n",
       " 'Mycophenolate',\n",
       " 'Mofetil',\n",
       " 'Procedure',\n",
       " ':',\n",
       " 'Peripheral',\n",
       " 'Blood',\n",
       " 'Stem',\n",
       " 'Cell',\n",
       " 'Transplantation',\n",
       " 'Tacrolimus',\n",
       " ...]"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "word_lst2 = []\n",
    "for i in range(len(words)):\n",
    "    for j in range(len(words[i])):\n",
    "\n",
    "        word_lst2.append(str(words[i][j]))\n",
    "    \n",
    "word_lst2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [],
   "source": [
    "word_lst2 = ''.join(word_lst2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [],
   "source": [
    "from wordcloud import WordCloud\n",
    "\n",
    "wordcloud = WordCloud(max_font_size=60).generate(word_lst2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(-0.5, 399.5, 199.5, -0.5)"
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1296x1008 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "plt.figure(figsize=(18, 14))\n",
    "plt.imshow(wordcloud, interpolation='bilinear')\n",
    "plt.axis(\"off\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
